<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Detailed analysis of bill sponsors and their potential conflicts of interest for the National Healthcare Reform Act of 2025">
    <title>Chanuka - Bill Sponsorship Transparency</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons" media="print" onload="this.media='all'">
    <link rel="stylesheet" href="css/bill-sponsorship.css">
    <link rel="stylesheet" href="css/sponsored.css">
    <link rel="stylesheet" href="css/merged_bill_sponsorship.css">

</head>
<body>
    <header>
        <nav>
            <a href="/" class="logo">
                <div class="logo-icon">C</div>
                Chanuka
            </a>
        </nav>
    </header>

    <nav aria-label="Breadcrumb" class="breadcrumb">
        <a href="/">Home</a>
        <span class="separator">‚Ä∫</span>
        <a href="/bills">Bills</a>
        <span class="separator">‚Ä∫</span>
        <span class="current">Bill Sponsorship Analysis</span>
    </nav>

    <main class="container">
        <a href="/" class="back-link">Back to Overview</a>
        <h1 class="page-title">Bill Sponsorship Transparency</h1>

        <div class="info-box">
            <p>This analysis provides detailed insights into bill sponsors and their potential conflicts of interest, combining official records, financial disclosures, and verified public information to ensure transparency in legislative processes.</p>
        </div>

        <div class="bill-main-card">
            <h2 class="bill-title">National Healthcare Reform Act of 2025</h2>
            <div class="bill-meta">
                <div class="meta-item">
                    <span class="material-icons">calendar_today</span>
                    <span>Introduced: <strong>March 15, 2025</strong></span>
                </div>
                <div class="meta-item">
                    <span class="material-icons">person</span>
                    <span>Primary Sponsor: <strong>Hon. James Mwangi</strong></span>
                </div>
                <div class="meta-item">
                    <span class="material-icons">groups</span>
                    <span>Co-Sponsors: <strong>12</strong></span>
                </div>
                <div class="meta-item">
                    <span class="material-icons">warning</span>
                    <span>Conflict Risk: <strong class="status-badge warning">Medium</strong></span>
                </div>
            </div>

            <p>A comprehensive healthcare reform proposal addressing insurance requirements, hospital funding, and pharmaceutical regulations.</p>
        </main>

    <!-- Enhanced Progressive Disclosure Navigation with Mobile Support -->
        <div class="progressive-navigation">
            <!-- Context Navigation Helper -->
            <div class="context-nav">
                <div class="current-location">
                    <span class="location-label">You are viewing:</span>
                    <strong id="current-section">Bill Overview</strong>
                </div>
                <div class="quick-actions">
                    <button class="btn-secondary" id="jump-to-summary" title="Jump to key findings">
                        <span class="material-icons">summarize</span>
                        <span class="btn-text">Key Findings</span>
                    </button>
                    <button class="btn-secondary" id="compare-sponsors" title="Compare all sponsors">
                        <span class="material-icons">compare</span>
                        <span class="btn-text">Compare</span>
                    </button>
                </div>
            </div>

            <div class="nav-header">
                <h3>Explore Bill Analysis</h3>
                <div class="user-controls">
                    <button class="control-btn" id="expand-all" title="Expand all sections">
                        <span class="material-icons">unfold_more</span>
                        <span class="btn-text">Expand All</span>
                    </button>
                    <button class="control-btn" id="collapse-all" title="Collapse all sections">
                        <span class="material-icons">unfold_less</span>
                        <span class="btn-text">Collapse All</span>
                    </button>
                    <button class="control-btn" id="reading-mode" title="Toggle reading mode">
                        <span class="material-icons">chrome_reader_mode</span>
                        <span class="btn-text">Focus Mode</span>
                    </button>
                </div>
            </div>

            <!-- Mobile Tab Selector -->
            <div class="mobile-tab-selector">
                <label for="mobile-tab-select" class="sr-only">Select section to view</label>
                <select id="mobile-tab-select" class="tab-selector" aria-label="Select section">
                    <option value="overview">üìä Quick Overview (2-3 min)</option>
                    <option value="primary-sponsor">üë§ Primary Sponsor (5-8 min)</option>
                    <option value="co-sponsors">üë• Co-Sponsors (5-8 min)</option>
                    <option value="financial-network">üåê Financial Network (10+ min)</option>
                    <option value="methodology">üî¨ Methodology (10+ min)</option>
                </select>
            </div>

            <div class="tab-navigation enhanced">
                <div class="tab active" data-tab="overview" data-complexity="low">
                    <span class="tab-icon material-icons">dashboard</span>
                    <div class="tab-content-preview">
                        <span class="tab-title">Quick Overview</span>
                        <span class="tab-subtitle">Key insights & summary</span>
                    </div>
                    <span class="complexity-indicator low">‚óè</span>
                </div>
                <div class="tab" data-tab="primary-sponsor" data-complexity="medium">
                    <span class="tab-icon material-icons">person</span>
                    <div class="tab-content-preview">
                        <span class="tab-title">Primary Sponsor</span>
                        <span class="tab-subtitle">Detailed conflict analysis</span>
                    </div>
                    <span class="complexity-indicator medium">‚óè</span>
                </div>
                <div class="tab" data-tab="co-sponsors" data-complexity="medium">
                    <span class="tab-icon material-icons">groups</span>
                    <div class="tab-content-preview">
                        <span class="tab-title">Co-Sponsors</span>
                        <span class="tab-subtitle">12 sponsor profiles</span>
                    </div>
                    <span class="complexity-indicator medium">‚óè</span>
                </div>
                <div class="tab" data-tab="financial-network" data-complexity="high">
                    <span class="tab-icon material-icons">account_tree</span>
                    <div class="tab-content-preview">
                        <span class="tab-title">Financial Network</span>
                        <span class="tab-subtitle">Comprehensive mapping</span>
                    </div>
                    <span class="complexity-indicator high">‚óè</span>
                </div>
                <div class="tab" data-tab="methodology" data-complexity="high">
                    <span class="tab-icon material-icons">science</span>
                    <div class="tab-content-preview">
                        <span class="tab-title">Methodology</span>
                        <span class="tab-subtitle">Analysis framework</span>
                    </div>
                    <span class="complexity-indicator high">‚óè</span>
                </div>
            </div>

            <div class="complexity-legend">
                <span class="legend-item">
                    <span class="complexity-indicator low">‚óè</span>
                    <span>Quick Read (2-3 min)</span>
                </span>
                <span class="legend-item">
                    <span class="complexity-indicator medium">‚óè</span>
                    <span>Detailed (5-8 min)</span>
                </span>
                <span class="legend-item">
                    <span class="complexity-indicator high">‚óè</span>
                    <span>Comprehensive (10+ min)</span>
                </span>
            </div>
        </div>
      <!-- New Overview Tab with Progressive Disclosure -->
      <div class="tab-content active" id="overview">
        <div class="overview-dashboard">
          <div class="dashboard-header">
            <h2>Bill Analysis at a Glance</h2>
            <p class="dashboard-subtitle">Essential insights about the National Healthcare Reform Act of 2025</p>
          </div>

          <!-- Critical Insights Panel -->
          <div class="critical-insights">
            <h3>üö® Key Transparency Concerns</h3>
            <div class="insight-cards">
              <div class="insight-card critical">
                <div class="insight-icon">üí∞</div>
                <div class="insight-content">
                  <h4>KSh 28.7M Financial Exposure</h4>
                  <p>Primary sponsor has significant pharmaceutical investments directly affected by this bill</p>
                  <button class="learn-more-btn" data-target="primary-sponsor" data-subtab="sponsor-financial">Learn More</button>
                </div>
              </div>
              <div class="insight-card warning">
                <div class="insight-icon">üë•</div>
                <div class="insight-content">
                  <h4>4 High-Risk Co-Sponsors</h4>
                  <p>One-third of co-sponsors have significant conflicts of interest</p>
                  <button class="learn-more-btn" data-target="co-sponsors" data-subtab="co-sponsors-analysis">Learn More</button>
                </div>
              </div>
              <div class="insight-card info">
                <div class="insight-icon">üè¢</div>
                <div class="insight-content">
                  <h4>KSh 142.8M Industry Backing</h4>
                  <p>Substantial financial support from healthcare industry</p>
                  <button class="learn-more-btn" data-target="financial-network" data-subtab="backers-corporate">Learn More</button>
                </div>
              </div>
            </div>
          </div>

          <!-- Quick Stats Grid -->
          <div class="quick-stats-grid">
            <div class="stat-category">
              <h4>Sponsor Analysis</h4>
              <div class="stats-row">
                <div class="stat-item">
                  <span class="stat-number">1</span>
                  <span class="stat-label">Primary Sponsor</span>
                  <span class="risk-indicator medium">Medium Risk</span>
                </div>
                <div class="stat-item">
                  <span class="stat-number">12</span>
                  <span class="stat-label">Co-Sponsors</span>
                  <span class="risk-breakdown">4 High, 6 Medium, 2 Low Risk</span>
                </div>
              </div>
            </div>

            <div class="stat-category">
              <h4>Financial Network</h4>
              <div class="stats-row">
                <div class="stat-item">
                  <span class="stat-number">68%</span>
                  <span class="stat-label">Industry Funding</span>
                  <span class="detail">Healthcare & Pharma</span>
                </div>
                <div class="stat-item">
                  <span class="stat-number">5</span>
                  <span class="stat-label">Major Backers</span>
                  <span class="detail">74% of total funding</span>
                </div>
              </div>
            </div>
          </div>

          <!-- Progressive Exploration Guide -->
          <div class="exploration-guide">
            <h3>üó∫Ô∏è Recommended Reading Path</h3>
            <div class="reading-path">
              <div class="path-step current">
                <div class="step-number">1</div>
                <div class="step-content">
                  <h4>You are here: Overview</h4>
                  <p>Getting the big picture</p>
                </div>
              </div>
              <div class="path-arrow">‚Üí</div>
              <div class="path-step next" data-target="primary-sponsor">
                <div class="step-number">2</div>
                <div class="step-content">
                  <h4>Primary Sponsor Deep Dive</h4>
                  <p>Detailed conflict analysis</p>
                  <button class="path-btn">Start Here</button>
                </div>
              </div>
              <div class="path-arrow">‚Üí</div>
              <div class="path-step" data-target="co-sponsors">
                <div class="step-number">3</div>
                <div class="step-content">
                  <h4>Co-Sponsors Review</h4>
                  <p>Broader sponsor network</p>
                </div>
              </div>
              <div class="path-arrow">‚Üí</div>
              <div class="path-step" data-target="financial-network">
                <div class="step-number">4</div>
                <div class="step-content">
                  <h4>Financial Mapping</h4>
                  <p>Complete influence network</p>
                </div>
              </div>
            </div>
          </div>

          <!-- Expandable Summary Sections -->
          <div class="expandable-summaries">
            <div class="summary-section">
              <button class="summary-toggle" data-target="bill-summary">
                <span class="material-icons">expand_more</span>
                <h4>Bill Summary & Key Provisions</h4>
                <span class="read-time">2 min read</span>
              </button>
              <div class="summary-content collapsed" id="bill-summary">
                <p>The National Healthcare Reform Act of 2025 introduces comprehensive changes to Kenya's healthcare system, with particular focus on pharmaceutical pricing (Sections 4-7), market access expansion (Sections 12-14), and insurance requirements.</p>
                <div class="key-provisions">
                  <h5>Most Controversial Provisions:</h5>
                  <ul>
                    <li><strong>Sections 4-7:</strong> Pharmaceutical pricing deregulation</li>
                    <li><strong>Sections 12-14:</strong> Expanded market access for private providers</li>
                    <li><strong>Section 18:</strong> Insurance mandate modifications</li>
                  </ul>
                </div>
              </div>
            </div>

            <div class="summary-section">
              <button class="summary-toggle" data-target="transparency-summary">
                <span class="material-icons">expand_more</span>
                <h4>Transparency Assessment Summary</h4>
                <span class="read-time">3 min read</span>
              </button>
              <div class="summary-content collapsed" id="transparency-summary">
                <p>Our analysis reveals moderate to high transparency concerns across the sponsor network, with particular attention needed for financial disclosure completeness and potential conflicts of interest.</p>
                <div class="assessment-breakdown">
                  <div class="assessment-item">
                    <span class="assessment-label">Financial Disclosure:</span>
                    <span class="assessment-score moderate">Moderate</span>
                  </div>
                  <div class="assessment-item">
                    <span class="assessment-label">Conflict Management:</span>
                    <span class="assessment-score needs-improvement">Needs Improvement</span>
                  </div>
                  <div class="assessment-item">
                    <span class="assessment-label">Public Engagement:</span>
                    <span class="assessment-score good">Good</span>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>

      <div class="tab-content" id="primary-sponsor">
        <div class="subtabs-container enhanced" id="primary-sponsor-subtabs">
            <!-- Progressive Disclosure Header -->
            <div class="subtab-header">
                <h3>Hon. James Mwangi - Primary Sponsor Analysis</h3>
                <div class="analysis-controls">
                    <div class="complexity-selector">
                        <label for="detail-level">Detail Level:</label>
                        <select id="detail-level" title="Select detail level" aria-label="Select detail level">
                            <option value="summary">Summary View</option>
                            <option value="detailed" selected>Detailed Analysis</option>
                            <option value="comprehensive">Comprehensive Report</option>
                        </select>
                    </div>
                    <button class="bookmark-btn" title="Bookmark this analysis">
                        <span class="material-icons">bookmark_border</span>
                    </button>
                </div>
            </div>

            <!-- Enhanced Subtabs with Progressive Disclosure -->
            <div class="subtabs enhanced" role="tablist" aria-label="Primary Sponsor Analysis">
                <button class="subtab is-active" role="tab" id="tab-sponsor-summary" aria-controls="sponsor-summary" aria-selected="true" data-complexity="low" tabindex="0">
                    <span class="subtab-icon material-icons">summarize</span>
                    <div class="subtab-content">
                        <span class="subtab-title">Quick Summary</span>
                        <span class="subtab-meta">Key conflicts & risks</span>
                    </div>
                    <span class="read-time">2 min</span>
                </button>

                <button class="subtab" role="tab" id="tab-sponsor-financial" aria-controls="sponsor-financial" aria-selected="false" data-complexity="medium" tabindex="-1">
                    <span class="subtab-icon material-icons">account_balance</span>
                    <div class="subtab-content">
                        <span class="subtab-title">Financial Analysis</span>
                        <span class="subtab-meta">KSh 28.7M exposure</span>
                    </div>
                    <span class="read-time">5 min</span>
                </button>

                <button class="subtab" role="tab" id="tab-sponsor-impact" aria-controls="sponsor-impact" aria-selected="false" data-complexity="medium" tabindex="-1">
                    <span class="subtab-icon material-icons">gps_fixed</span>
                    <div class="subtab-content">
                        <span class="subtab-title">Bill Impact</span>
                        <span class="subtab-meta">Direct provisions affected</span>
                    </div>
                    <span class="read-time">4 min</span>
                </button>

                <button class="subtab" role="tab" id="tab-sponsor-network" aria-controls="sponsor-network" aria-selected="false" data-complexity="high" tabindex="-1">
                    <span class="subtab-icon material-icons">account_tree</span>
                    <div class="subtab-content">
                        <span class="subtab-title">Network Analysis</span>
                        <span class="subtab-meta">Organizational ties</span>
                    </div>
                    <span class="read-time">6 min</span>
                </button>

                <button class="subtab" role="tab" id="tab-sponsor-accountability" aria-controls="sponsor-accountability" aria-selected="false" data-complexity="medium" tabindex="-1">
                    <span class="subtab-icon material-icons">balance</span>
                    <div class="subtab-content">
                        <span class="subtab-title">Accountability</span>
                        <span class="subtab-meta">Transparency measures</span>
                    </div>
                    <span class="read-time">3 min</span>
                </button>
            </div>

            <!-- Content Navigation Helper -->
            <div class="content-navigator">
                <div class="nav-progress">
                    <div class="progress-bar" role="progressbar" aria-valuenow="20" aria-valuemin="0" aria-valuemax="100" aria-label="Reading progress">
                        <div class="progress-fill" style="width: 20%"></div>
                    </div>
                    <span class="progress-text">Section 1 of 5</span>
                </div>
                <div class="nav-actions">
                    <button class="nav-btn prev" disabled>
                        <span class="material-icons">chevron_left</span>
                        Previous
                    </button>
                    <button class="nav-btn next">
                        Next
                        <span class="material-icons">chevron_right</span>
                    </button>
                </div>
            </div>
        </div>

        <!-- Quick Summary Panel -->
        <div class="subpanel is-active" id="sponsor-summary" role="tabpanel" aria-labelledby="tab-sponsor-summary" tabindex="0" aria-hidden="false">
            <div class="summary-dashboard">
                <div class="sponsor-card compact">
                    <div class="sponsor-header">
                        <div class="sponsor-avatar">
                            <img src="https://via.placeholder.com/60x60" alt="Hon. James Mwangi">
                        </div>
                        <div class="sponsor-info">
                            <h3>Hon. James Mwangi</h3>
                            <p class="sponsor-title">MP - Kiambu County | Jubilee Party</p>
                            <div class="risk-indicator high">
                                <span class="material-icons">warning</span>
                                High Conflict Risk
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Critical Insights -->
                <div class="critical-insights">
                    <h4>üö® Key Transparency Concerns</h4>
                    <div class="insight-cards">
                        <div class="insight-card critical">
                            <div class="insight-icon">üí∞</div>
                            <div class="insight-content">
                                <h5>KSh 28.7M Financial Exposure</h5>
                                <p>Direct financial interests in companies affected by this bill</p>
                            </div>
                        </div>
                        <div class="insight-card warning">
                            <div class="insight-icon">üìã</div>
                            <div class="insight-content">
                                <h5>12 Matching Provisions</h5>
                                <p>Bill sections align with industry policy recommendations</p>
                            </div>
                        </div>
                        <div class="insight-card info">
                            <div class="insight-icon">üó≥Ô∏è</div>
                            <div class="insight-content">
                                <h5>73% Industry Alignment</h5>
                                <p>Historical voting pattern favors industry interests</p>
                            </div>
                        </div>
                    </div>
                </div>

                <!-- Quick Actions -->
                <div class="quick-actions">
                    <h4>Recommended Next Steps</h4>
                    <div class="action-buttons">
                        <button class="action-btn primary" onclick="document.getElementById('tab-sponsor-financial').click()">
                            <span class="material-icons">account_balance</span>
                            View Financial Details
                        </button>
                        <button class="action-btn secondary" onclick="document.getElementById('tab-sponsor-impact').click()">
                            <span class="material-icons">gps_fixed</span>
                            See Bill Impact
                        </button>
                        <button class="action-btn tertiary" onclick="expandSection('transparency-measures')">
                            <span class="material-icons">visibility</span>
                            Check Transparency
                        </button>
                    </div>
                </div>

                <!-- Expandable Summary Sections -->
                <div class="expandable-sections">
                    <div class="expandable-section" data-section="key-conflicts">
                        <div class="section-header" onclick="toggleSection(this)">
                            <h4>üîç Key Conflicts Overview</h4>
                            <span class="material-icons expand-icon">expand_more</span>
                        </div>
                        <div class="section-content">
                            <div class="conflict-summary">
                                <div class="conflict-item">
                                    <strong>East African Pharmaceuticals (KSh 15.2M)</strong>
                                    <p>Benefits from Section 4.2 licensing changes</p>
                                </div>
                                <div class="conflict-item">
                                    <strong>National Healthcare Alliance (Board Member)</strong>
                                    <p>Influences Section 7.1 equipment standards</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="expandable-section" data-section="timeline">
                        <div class="section-header" onclick="toggleSection(this)">
                            <h4>üìÖ Key Timeline Events</h4>
                            <span class="material-icons expand-icon">expand_more</span>
                        </div>
                        <div class="section-content">
                            <div class="mini-timeline">
                                <div class="timeline-point">
                                    <span class="date">Jan 2023</span>
                                    <span class="event">Acquired pharmaceutical shares</span>
                                </div>
                                <div class="timeline-point">
                                    <span class="date">Mar 2023</span>
                                    <span class="event">Joined healthcare board</span>
                                </div>
                                <div class="timeline-point">
                                    <span class="date">Apr 2023</span>
                                    <span class="event">Bill introduced</span>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Financial Analysis Panel -->
         <div class="subpanel" id="sponsor-financial" role="tabpanel" aria-labelledby="tab-sponsor-financial" tabindex="0" aria-hidden="true">
             <div class="financial-analysis-dashboard">
                 <div class="analysis-header">
                     <h3>üí∞ Financial Interest Analysis</h3>
                     <div class="total-exposure">
                         <span class="amount">KSh 28.7M</span>
                         <span class="label">Total Exposure</span>
                     </div>
                 </div>

                 <div class="financial-breakdown">
                     <div class="investment-card primary">
                         <div class="investment-header">
                             <h4>East African Pharmaceuticals</h4>
                             <span class="risk-level high">High Risk</span>
                         </div>
                         <div class="investment-details">
                             <div class="amount">KSh 15.2M (53% of total exposure)</div>
                             <div class="stake">12% ownership stake</div>
                             <div class="acquisition-date">Acquired: January 2023</div>
                             <div class="bill-impact">
                                 <strong>Bill Impact:</strong> Sections 4.2, 6.1, 7.3 directly benefit this company
                             </div>
                         </div>
                     </div>

                     <div class="investment-card secondary">
                         <div class="investment-header">
                             <h4>National Healthcare Alliance</h4>
                             <span class="risk-level medium">Medium Risk</span>
                         </div>
                         <div class="investment-details">
                             <div class="role">Board Member (Non-Executive)</div>
                             <div class="compensation">Annual compensation: KSh 2.4M</div>
                             <div class="appointment-date">Appointed: March 2023</div>
                             <div class="bill-impact">
                                 <strong>Bill Impact:</strong> Equipment standards in Section 7.1
                             </div>
                         </div>
                     </div>
                 </div>

                 <div class="financial-timeline">
                     <h4>üìà Financial Activity Timeline</h4>
                     <div class="timeline-chart">
                         <div class="timeline-item">
                             <div class="date">Jan 2023</div>
                             <div class="event">Pharmaceutical investment</div>
                             <div class="amount">+KSh 15.2M</div>
                         </div>
                         <div class="timeline-item">
                             <div class="date">Mar 2023</div>
                             <div class="event">Board appointment</div>
                             <div class="amount">+KSh 2.4M/year</div>
                         </div>
                         <div class="timeline-item critical">
                             <div class="date">Apr 2023</div>
                             <div class="event">Bill introduction</div>
                             <div class="impact">Potential 15-25% value increase</div>
                         </div>
                     </div>
                 </div>
             </div>
         </div>

         <!-- Bill Impact Panel -->
         <div class="subpanel" id="sponsor-impact" role="tabpanel" aria-labelledby="tab-sponsor-impact" tabindex="0" aria-hidden="true">
             <div class="impact-analysis-dashboard">
                 <div class="analysis-header">
                     <h3>üéØ Direct Bill Impact Analysis</h3>
                     <div class="impact-summary">
                         <span class="affected-sections">12 Sections</span>
                         <span class="label">Directly Affected</span>
                     </div>
                 </div>

                 <div class="bill-sections-grid">
                     <div class="section-card critical">
                         <div class="section-header">
                             <h4>Section 4.2: Healthcare Provider Licensing</h4>
                             <span class="impact-level">Critical Impact</span>
                         </div>
                         <div class="section-content">
                             <div class="provision">Reduces licensing requirements for pharmaceutical distributors</div>
                             <div class="financial-benefit">
                                 <strong>Financial Benefit:</strong> East African Pharmaceuticals saves ~KSh 8.5M annually
                             </div>
                             <div class="conflict-indicator">
                                 <span class="material-icons">warning</span>
                                 Direct financial conflict identified
                             </div>
                         </div>
                     </div>

                     <div class="section-card high">
                         <div class="section-header">
                             <h4>Section 7.1: Medical Equipment Standards</h4>
                             <span class="impact-level">High Impact</span>
                         </div>
                         <div class="section-content">
                             <div class="provision">Streamlines equipment certification processes</div>
                             <div class="organizational-benefit">
                                 <strong>Organizational Benefit:</strong> Aligns with National Healthcare Alliance advocacy
                             </div>
                             <div class="conflict-indicator">
                                 <span class="material-icons">info</span>
                                 Governance conflict identified
                             </div>
                         </div>
                     </div>

                     <div class="section-card medium">
                         <div class="section-header">
                             <h4>Section 12.3: Market Access Provisions</h4>
                             <span class="impact-level">Medium Impact</span>
                         </div>
                         <div class="section-content">
                             <div class="provision">Expands market access for private healthcare providers</div>
                             <div class="indirect-benefit">
                                 <strong>Indirect Benefit:</strong> Increases market opportunities for portfolio companies
                             </div>
                         </div>
                     </div>
                 </div>

                 <div class="provision-analysis">
                     <h4>üìã Provision Similarity Analysis</h4>
                     <div class="similarity-cards">
                         <div class="similarity-item">
                             <div class="similarity-score">89%</div>
                             <div class="similarity-details">
                                 <strong>Section 4.2</strong> matches sponsor's 2022 policy paper on pharmaceutical regulation
                             </div>
                         </div>
                         <div class="similarity-item">
                             <div class="similarity-score">76%</div>
                             <div class="similarity-details">
                                 <strong>Section 7.1</strong> aligns with National Healthcare Alliance recommendations
                             </div>
                         </div>
                     </div>
                 </div>
             </div>
         </div>

         <!-- Network Analysis Panel -->
         <div class="subpanel" id="sponsor-network" role="tabpanel" aria-labelledby="tab-sponsor-network" tabindex="0" aria-hidden="true">
             <div class="network-analysis-dashboard">
                 <div class="analysis-header">
                     <h3>üï∏Ô∏è Organizational Network Analysis</h3>
                     <div class="network-summary">
                         <span class="connections">15 Key</span>
                         <span class="label">Connections</span>
                     </div>
                 </div>

                 <div class="network-visualization">
                     <div class="network-center">
                         <div class="sponsor-node">
                             <div class="node-avatar">JM</div>
                             <div class="node-label">Hon. James Mwangi</div>
                         </div>
                     </div>

                     <div class="network-connections">
                         <div class="connection-group financial">
                             <h4>üí∞ Financial Connections</h4>
                             <div class="connection-item critical">
                                 <div class="connection-details">
                                     <strong>East African Pharmaceuticals</strong>
                                     <span class="connection-type">Major Shareholder (12%)</span>
                                     <span class="value">KSh 15.2M</span>
                                 </div>
                             </div>
                             <div class="connection-item">
                                 <div class="connection-details">
                                     <strong>Afya Health Systems</strong>
                                     <span class="connection-type">Former Board Member</span>
                                     <span class="value">2019-2021</span>
                                 </div>
                             </div>
                         </div>

                         <div class="connection-group governance">
                             <h4>üèõÔ∏è Governance Roles</h4>
                             <div class="connection-item">
                                 <div class="connection-details">
                                     <strong>National Healthcare Alliance</strong>
                                     <span class="connection-type">Board Member</span>
                                     <span class="value">Current</span>
                                 </div>
                             </div>
                             <div class="connection-item">
                                 <div class="connection-details">
                                     <strong>Medical Infrastructure Coalition</strong>
                                     <span class="connection-type">Advisory Director</span>
                                     <span class="value">2022-Present</span>
                                 </div>
                             </div>
                         </div>

                         <div class="connection-group professional">
                             <h4>üë• Professional Affiliations</h4>
                             <div class="connection-item">
                                 <div class="connection-details">
                                     <strong>Kenya Medical Association</strong>
                                     <span class="connection-type">Advisory Committee</span>
                                 </div>
                             </div>
                             <div class="connection-item">
                                 <div class="connection-details">
                                     <strong>Parliamentary Health Committee</strong>
                                     <span class="connection-type">Chairperson</span>
                                 </div>
                             </div>
                         </div>
                     </div>
                 </div>

                 <div class="influence-mapping">
                     <h4>üìä Influence Pathway Analysis</h4>
                     <div class="influence-paths">
                         <div class="influence-path">
                             <div class="path-steps">
                                 <div class="step">Sponsor Role</div>
                                 <div class="arrow">‚Üí</div>
                                 <div class="step">Committee Chair</div>
                                 <div class="arrow">‚Üí</div>
                                 <div class="step">Bill Provisions</div>
                                 <div class="arrow">‚Üí</div>
                                 <div class="step">Financial Benefit</div>
                             </div>
                             <div class="path-impact">Direct legislative influence pathway</div>
                         </div>
                     </div>
                 </div>
             </div>
         </div>

         <!-- Accountability Panel -->
         <div class="subpanel" id="sponsor-accountability" role="tabpanel" aria-labelledby="tab-sponsor-accountability" tabindex="0" aria-hidden="true">
             <div class="accountability-dashboard">
                 <div class="analysis-header">
                     <h3>‚öñÔ∏è Transparency & Accountability Measures</h3>
                     <div class="transparency-score">
                         <span class="score moderate">6.2/10</span>
                         <span class="label">Transparency Score</span>
                     </div>
                 </div>

                 <div class="accountability-sections">
                     <div class="accountability-card">
                         <div class="card-header">
                             <h4>üìã Disclosure Status</h4>
                             <span class="status partial">Partial</span>
                         </div>
                         <div class="card-content">
                             <div class="disclosure-item complete">
                                 <span class="material-icons">check_circle</span>
                                 <span>Financial interests declared in parliamentary register</span>
                             </div>
                             <div class="disclosure-item incomplete">
                                 <span class="material-icons">cancel</span>
                                 <span>Board compensation details not publicly disclosed</span>
                             </div>
                             <div class="disclosure-item incomplete">
                                 <span class="material-icons">cancel</span>
                                 <span>Voting rationale not provided for conflicted bills</span>
                             </div>
                         </div>
                     </div>

                     <div class="accountability-card">
                         <div class="card-header">
                             <h4>üõ°Ô∏è Conflict Management</h4>
                             <span class="status inadequate">Inadequate</span>
                         </div>
                         <div class="card-content">
                             <div class="management-item">
                                 <strong>Recusal Policy:</strong> No formal recusal from conflicted votes
                             </div>
                             <div class="management-item">
                                 <strong>Ethics Review:</strong> No independent ethics review conducted
                             </div>
                             <div class="management-item">
                                 <strong>Public Consultation:</strong> Limited stakeholder engagement on conflicts
                             </div>
                         </div>
                     </div>

                     <div class="accountability-card">
                         <div class="card-header">
                             <h4>üìä Recommended Actions</h4>
                         </div>
                         <div class="card-content">
                             <div class="recommendation priority-high">
                                 <span class="priority">High Priority</span>
                                 <span class="action">Recuse from voting on Sections 4.2 and 7.1</span>
                             </div>
                             <div class="recommendation priority-medium">
                                 <span class="priority">Medium Priority</span>
                                 <span class="action">Disclose board compensation details</span>
                             </div>
                             <div class="recommendation priority-medium">
                                 <span class="priority">Medium Priority</span>
                                 <span class="action">Establish independent ethics review process</span>
                             </div>
                         </div>
                     </div>
                 </div>
             </div>
         </div>

         <div class="sponsor-details">
            <!-- Bill-Specific Conflict Mapping -->
            <div class="detail-section priority-section">
                <h4>
                    <span class="material-icons">gps_fixed</span>
                    Direct Bill Impact Analysis
                </h4>
                <div class="bill-impact-grid">
                    <div class="impact-item high-impact">
                        <div class="impact-header">
                            <span class="section-reference">Sections 4-7: Pharmaceutical Pricing</span>
                            <span class="impact-level badge badge-danger">High Impact</span>
                        </div>
                        <div class="impact-details">
                            <div class="financial-connection">
                                <strong>Financial Interest:</strong> KSh 28.7M shareholding in East African Pharmaceuticals
                            </div>
                            <div class="potential-benefit">
                                <strong>Potential Impact:</strong> Reduced regulatory burden could increase company valuation by 15-25%
                            </div>
                        </div>
                    </div>

                    <div class="impact-item medium-impact">
                        <div class="impact-header">
                            <span class="section-reference">Sections 12-14: Market Access Expansion</span>
                            <span class="impact-level badge badge-warning">Medium Impact</span>
                        </div>
                        <div class="impact-details">
                            <div class="organizational-connection">
                                <strong>Advisory Role:</strong> Medical Infrastructure Coalition (Director)
                            </div>
                            <div class="potential-benefit">
                                <strong>Potential Impact:</strong> Expanded market access aligns with coalition's advocacy positions
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Enhanced Financial Interest Timeline with Bill Context -->
            <div class="detail-section">
                <h4>
                    <span class="material-icons">timeline</span>
                    Financial Interest Timeline & Legislative Activity
                </h4>
                <div class="timeline-container">
                    <div class="timeline-event past">
                        <div class="timeline-date">2019-2021</div>
                        <div class="timeline-content">
                            <strong>Board Member</strong> - Afya Health Systems Ltd.
                            <span class="timeline-impact">Annual compensation: KSh 6.1M-10.9M</span>
                            <div class="legislative-activity">
                                <em>During this period: Sponsored 3 healthcare infrastructure bills in Parliament</em>
                            </div>
                        </div>
                    </div>
                    <div class="timeline-event current critical">
                        <div class="timeline-date">2021-Present</div>
                        <div class="timeline-content">
                            <strong>Major Shareholder</strong> - East African Pharmaceuticals
                            <span class="timeline-impact">Current holdings value: KSh 28.7M (12% stake)</span>
                            <div class="impact-alert">
                                <span class="material-icons">warning</span>
                                <strong>This bill directly affects pharmaceutical pricing and distribution under Kenya's healthcare policy</strong>
                            </div>
                            <div class="legislative-activity">
                                <em>Since acquiring stake: Voted on 8 pharmaceutical-related bills in Parliament, supporting industry position 7 times</em>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Enhanced Organizational Ties with Influence Mapping -->
            <div class="detail-section">
                <h4>
                    <span class="material-icons">account_tree</span>
                    Organizational Network & Policy Influence
                </h4>
                <ul class="affiliation-list enhanced">
                    <li class="affiliation-item high-relevance">
                        <div class="affiliation-details">
                            <div class="affiliation-name">
                                <span>African Policy Foundation</span>
                                <span class="relevance-indicator">Direct Policy Influence</span>
                            </div>
                            <div class="affiliation-meta">
                                <span class="badge badge-warning">Advisory Board Member</span>
                                <span class="influence-metric">7 bill provisions match foundation papers</span>
                            </div>
                            <div class="funding-transparency">
                                <strong>Foundation Funding Sources:</strong> 60% Kenyan healthcare industry, 25% East African pharmaceutical companies, 15% development partners and grants
                            </div>                        </div>
                    </li>
                    <li class="affiliation-item medium-relevance">
                        <div class="affiliation-details">
                            <div class="affiliation-name">
                                <span>Medical Infrastructure Coalition</span>
                                <span class="relevance-indicator">Policy Advocacy</span>
                            </div>
                            <div class="affiliation-meta">
                                <span class="badge badge-primary">Director</span>
                                <span class="influence-metric">Coalition lobbied for similar provisions</span>
                            </div>
                        </div>
                    </li>
                </ul>
            </div>

            <!-- Enhanced Intelligence Sources with Verification -->
            <div class="detail-section">
                <h4>
                    <span class="material-icons">fact_check</span>
                    Verified Intelligence Sources
                </h4>

                <div class="source-item verified">
                    <div class="source-icon">
                        <span class="material-icons">article</span>
                    </div>
                    <div class="source-details">
                        <div class="source-meta">
                            <div class="source-name">The Standard Business Review</div>
                            <div class="source-date">February 12, 2025</div>
                            <div class="verification-status verified">Independently Verified</div>
                        </div>
                        <p><strong>Key Finding:</strong> Documented meeting between Hon. Mwangi and executives from three major pharmaceutical companies operating in Kenya two weeks before bill introduction.</p>
                        <div class="source-impact">
                            <strong>Transparency Impact:</strong> Meeting occurred during bill drafting period, suggesting potential industry input in legislation development affecting Kenya's pharmaceutical sector.
                        </div>
                        <div class="source-credibility">
                            <div>Source Credibility:</div>
                            <div class="credibility-meter">
                                <div class="credibility-level" style="width: 85%; background-color: var(--success);"></div>
                            </div>
                            <div class="credibility-score">8.5/10</div>
                        </div>
                    </div>
                </div>

                <div class="source-item cross-referenced">
                    <div class="source-icon">
                        <span class="material-icons">analytics</span>
                    </div>
                    <div class="source-details">
                        <div class="source-meta">
                            <div class="source-name">AI Policy Analysis System</div>
                            <div class="source-date">Continuous Monitoring</div>
                            <div class="verification-status automated">AI-Verified</div>
                        </div>
                        <p><strong>Pattern Analysis:</strong> Sections 8, 12, and 15 show 70%+ similarity to pharmaceutical industry position papers from 2022-2024, including language matching East African pharmaceutical sector recommendations.</p>
                        <div class="source-impact">
                            <strong>Transparency Impact:</strong> Suggests potential direct influence of Kenyan industry drafting on final legislation language, particularly provisions affecting local pharmaceutical market access.
                        </div>
                    </div>
                </div>
            </div>

            <!-- Strategic Public Accountability Framework -->
            <div class="detail-section">
                <h4>
                    <span class="material-icons">balance</span>
                    Accountability & Transparency Measures
                </h4>
                <div class="accountability-grid enhanced">
                    <div class="accountability-item compliant">
                        <span class="material-icons">assignment_turned_in</span>
                        <div class="accountability-content">
                            <strong>Disclosure Status: Complete</strong>
                            <p>Last updated: January 15, 2025</p>
                            <div class="disclosure-detail">All required financial interests disclosed per National Assembly Standing Orders and Public Officer Ethics Act</div>
                        </div>
                    </div>
                    <div class="accountability-item concerning">
                        <span class="material-icons">record_voice_over</span>
                        <div class="accountability-content">
                            <strong>Public Position Statements</strong>
                            <p>3 statements addressing conflicts</p>
                            <div class="disclosure-detail">No public statement on East African Pharmaceuticals stake relationship to this bill</div>
                        </div>
                    </div>
                    <div class="accountability-item partial">
                        <span class="material-icons">how_to_vote</span>
                        <div class="accountability-content">
                            <strong>Recusal History</strong>
                            <p>2 recusals in past year</p>
                            <div class="disclosure-detail">Has not indicated intention to recuse from votes on this bill</div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Strategic Risk Assessment with Recommendations -->
        <div class="comprehensive-risk-assessment">
            <h4>Strategic Transparency Assessment</h4>
            <div class="risk-breakdown enhanced">
                <div class="risk-category">
                    <span class="risk-label">Financial Interest Magnitude:</span>
                    <div class="risk-meter high">
                        <div class="risk-fill" style="width: 75%"></div>
                        <span>High (KSh 28.7M direct exposure)</span>
                    </div>
                </div>
                <div class="risk-category">
                    <span class="risk-label">Bill Impact on Interests:</span>
                    <div class="risk-meter critical">
                        <div class="risk-fill" style="width: 90%"></div>
                        <span>Critical (Direct regulatory impact)</span>
                    </div>
                </div>
                <div class="risk-category">
                    <span class="risk-label">Public Transparency Level:</span>
                    <div class="risk-meter moderate">
                        <div class="risk-fill" style="width: 60%"></div>
                        <span>Moderate (Partial disclosure)</span>
                    </div>
                </div>
            </div>

            <div class="transparency-recommendations">
                <h5>Recommended Transparency Enhancements:</h5>
                <div class="recommendation-list">
                    <div class="recommendation critical">
                        <span class="material-icons">priority_high</span>
                        <div class="recommendation-content">
                            <strong>Immediate:</strong> Public statement addressing relationship between pharmaceutical holdings and bill provisions
                        </div>
                    </div>
                    <div class="recommendation important">
                        <span class="material-icons">visibility</span>
                        <div class="recommendation-content">
                            <strong>Process:</strong> Independent review of bill sections affecting pharmaceutical sector
                        </div>
                    </div>
                    <div class="recommendation suggested">
                        <span class="material-icons">gavel</span>
                        <div class="recommendation-content">
                            <strong>Governance:</strong> Consider recusal from votes on sections 4-7 and 12-14
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Citizen Engagement Interface -->
        <div class="citizen-engagement-section">
            <h4>
                <span class="material-icons">how_to_reg</span>
                Public Engagement & Feedback
            </h4>
            <div class="engagement-options">
                <div class="engagement-item">
                    <button class="engagement-btn request-statement">
                        <span class="material-icons">campaign</span>
                        Request Public Statement on Conflicts
                    </button>
                    <span class="engagement-count">127 citizens have requested this</span>
                </div>
                <div class="engagement-item">
                    <button class="engagement-btn submit-concern">
                        <span class="material-icons">report_problem</span>
                        Submit Transparency Concern
                    </button>
                    <span class="engagement-count">23 concerns submitted</span>
                </div>
                <div class="engagement-item">
                    <button class="engagement-btn track-voting">
                        <span class="material-icons">track_changes</span>
                        Track Voting on This Bill
                    </button>
                    <span class="engagement-count">445 citizens tracking</span>
                </div>
            </div>
        </div>
    </div>
        </div>

        <div class="subpanel" id="co-sponsor-financial" role="tabpanel" aria-labelledby="tab-co-sponsor-financial" tabindex="0" aria-hidden="true">
            <h3>Co-Sponsor Financial Analysis</h3>
            <div class="financial-analysis-dashboard">
                <div class="analysis-header">
                    <h3>üí∞ Co-Sponsor Financial Interest Analysis</h3>
                    <div class="total-exposure">
                        <span class="amount">KSh 47.3M</span>
                        <span class="label">Total Industry Ties Value</span>
                    </div>
                </div>

                <div class="financial-breakdown">
                    <div class="investment-card primary">
                        <div class="investment-header">
                            <h4>Healthcare Industry Investments</h4>
                            <span class="risk-level high">High Risk</span>
                        </div>
                        <div class="investment-details">
                            <div class="amount">KSh 28.5M (60% of total exposure)</div>
                            <div class="stake">Across multiple co-sponsors</div>
                            <div class="bill-impact">
                                <strong>Bill Impact:</strong> Multiple sections directly benefit these investments
                            </div>
                        </div>
                    </div>

                    <div class="investment-card secondary">
                        <div class="investment-header">
                            <h4>Board Positions & Governance Roles</h4>
                            <span class="risk-level medium">Medium Risk</span>
                        </div>
                        <div class="investment-details">
                            <div class="role">7 co-sponsors hold board positions</div>
                            <div class="compensation">Annual compensation: ~KSh 18.8M combined</div>
                            <div class="bill-impact">
                                <strong>Bill Impact:</strong> Multiple regulatory provisions align with board interests
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div class="subpanel" id="co-sponsor-voting" role="tabpanel" aria-labelledby="tab-co-sponsor-voting" tabindex="0" aria-hidden="true">
            <h3>Co-Sponsor Voting History Analysis</h3>
            <p>Analysis of co-sponsors' voting patterns on similar healthcare legislation.</p>

            <div class="voting-history">
                <h4>Recent Healthcare Legislation Votes</h4>
                <div class="voting-record">
                    <div class="vote-item industry-aligned">
                        <div class="vote-date">March 2024</div>
                        <div class="vote-bill">Healthcare Pricing Transparency Act</div>
                        <div class="vote-position">8 co-sponsors voted Against</div>
                        <div class="industry-position">Industry Position: Against</div>
                    </div>
                    <div class="vote-item industry-aligned">
                        <div class="vote-date">November 2023</div>
                        <div class="vote-bill">Pharmaceutical Import Regulations</div>
                        <div class="vote-position">10 co-sponsors voted For</div>
                        <div class="industry-position">Industry Position: For</div>
                    </div>
                    <div class="vote-item industry-opposed">
                        <div class="vote-date">July 2023</div>
                        <div class="vote-bill">Generic Medication Access Bill</div>
                        <div class="vote-position">7 co-sponsors voted Against</div>
                        <div class="industry-position">Industry Position: Against</div>
                    </div>
                </div>
            </div>

            <section class="voting-trends" aria-labelledby="voting-trends-heading-2">
                    <h3 id="voting-trends-heading-2">Industry Alignment Trends</h3>
                <div class="trends-overview">
                    <div class="trend-metric">
                        <span class="trend-percentage">73%</span>
                        <span class="trend-label">Average Industry Alignment</span>
                        <p>Across all co-sponsors on healthcare votes (2022-2024)</p>
                    </div>
                    <div class="trend-metric">
                        <span class="trend-percentage">89%</span>
                        <span class="trend-label">High-Conflict Sponsors Alignment</span>
                        <p>Sponsors with significant financial interests</p>
                    </div>
                </div>
            </section>
        </div>

        <div class="subpanel" id="co-sponsor-engagement" role="tabpanel" aria-labelledby="tab-co-sponsor-engagement" tabindex="0" aria-hidden="true">
            <h3>Co-Sponsor Public Engagement & Transparency</h3>
            <div class="engagement-overview">
                <p>Analysis of co-sponsors' public engagement regarding the National Healthcare Reform Act and transparency in addressing potential conflicts of interest.</p>
            </div>

            <div class="engagement-activities">
                <h4>Recent Public Engagement</h4>
                <div class="activity-timeline">
                    <div class="activity-item">
                        <div class="activity-date">March 2025</div>
                        <div class="activity-content">
                            <strong>Public Town Halls - Multiple Locations</strong>
                            <p>5 co-sponsors held public forums addressing healthcare reform</p>
                            <span class="activity-type badge badge-success">Transparency Initiative</span>
                        </div>
                    </div>
                    <div class="activity-item">
                        <div class="activity-date">February 2025</div>
                        <div class="activity-content">
                            <strong>Parliamentary Committee Hearings</strong>
                            <p>8 co-sponsors testified on healthcare policy priorities</p>
                            <span class="activity-type badge badge-info">Official Testimony</span>
                        </div>
                    </div>
                    <div class="activity-item">
                        <div class="activity-date">January 2025</div>
                        <div class="activity-content">
                            <strong>Stakeholder Consultation Forums</strong>
                            <p>3 co-sponsors facilitated dialogue between healthcare stakeholders</p>
                            <span class="activity-type badge badge-warning">Multi-Stakeholder</span>
                        </div>
                    </div>
                </div>
            </div>

            <div class="transparency-measures">
                <h4>Transparency Commitments</h4>
                <div class="commitment-list">
                    <div class="commitment-item">
                        <span class="material-icons">visibility</span>
                        <div class="commitment-content">
                            <strong>Financial Disclosure Updates</strong>
                            <p>7 co-sponsors provide regular updates on healthcare investments</p>
                        </div>
                    </div>
                    <div class="commitment-item">
                        <span class="material-icons">forum</span>
                        <div class="commitment-content">
                            <strong>Public Q&A Sessions</strong>
                            <p>4 co-sponsors hold regular sessions for constituent questions</p>
                        </div>
                    </div>
                    <div class="commitment-item">
                        <span class="material-icons">description</span>
                        <div class="commitment-content">
                            <strong>Voting Rationale Publication</strong>
                            <p>6 co-sponsors publish explanations for healthcare-related votes</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</div>

      </div>

      <div class="tab-content" id="co-sponsors">
        <div class="subtabs-container" id="co-sponsors-subtabs">
            <nav class="subtabs" role="tablist" aria-label="Co-sponsors analysis navigation">
                <button class="subtab is-active" role="tab" aria-controls="co-sponsors-overview" aria-selected="true" id="overview-tab">Overview</button>
                <button class="subtab" role="tab" aria-controls="co-sponsors-analysis" aria-selected="false" id="analysis-tab">Conflict Analysis</button>
                <button class="subtab" role="tab" aria-controls="co-sponsors-patterns" aria-selected="false" id="patterns-tab">Voting Patterns</button>
                <button class="subtab" role="tab" aria-controls="co-sponsors-details" aria-selected="false" id="details-tab">Individual Details</button>
            </nav>

            <main class="subpanel is-active" id="co-sponsors-overview" role="tabpanel" aria-labelledby="overview-tab">
                <header class="co-sponsors-overview">
                    <h2>Co-Sponsors Conflict Analysis Dashboard</h2>
                    <p class="dashboard-description">Comprehensive analysis of all 12 co-sponsors examining financial interests, voting patterns, and potential conflicts with the National Healthcare Reform Act.</p>
                </header>

                <section class="sponsors-list" aria-labelledby="sponsors-heading">
                    <h3 id="sponsors-heading">Individual Co-Sponsor Profiles</h3>

                    <article class="sponsor-card high-risk" aria-labelledby="odhiambo-name">
                        <header class="sponsor-header">
                            <div class="sponsor-info">
                                <h4 class="sponsor-name" id="odhiambo-name">Hon. Sarah Odhiambo</h4>
                                <p class="sponsor-role">Member of Parliament - Kisumu East</p>
                            </div>
                            <div class="conflict-badge badge badge-danger" aria-label="High conflict risk assessment">High Conflict Risk</div>
                        </header>

                        <section class="affiliations" aria-labelledby="odhiambo-affiliations">
                            <h5 id="odhiambo-affiliations">Known Affiliations</h5>
                            <div class="sponsor-affiliation">
                                <span class="affiliation-icon" aria-hidden="true">üè¢</span>
                                <div class="affiliation-details">
                                    <strong>National Healthcare Alliance</strong> - Board Member (2020-Present)
                                    <span class="badge badge-danger">Direct COI</span>
                                </div>
                            </div>

                            <div class="sponsor-affiliation">
                                <span class="affiliation-icon" aria-hidden="true">üíº</span>
                                <div class="affiliation-details">
                                    <strong>Medical Research Foundation</strong> - Senior Advisor
                                    <span class="badge badge-warning">Indirect COI</span>
                                </div>
                            </div>
                        </section>

                        <section class="financial-disclosure" aria-labelledby="odhiambo-financial">
                            <h5 id="odhiambo-financial">Financial Disclosure</h5>
                            <p>Received significant campaign funding from healthcare industry groups in the last election cycle, totaling approximately KSh 2.8 million across multiple organizations.</p>
                        </section>

                        <footer class="sponsor-actions">
                            <button class="btn-outline" type="button" aria-describedby="odhiambo-analysis-desc">
                                View Detailed Analysis
                                <span id="odhiambo-analysis-desc" class="sr-only">Complete conflict analysis for Hon. Sarah Odhiambo</span>
                            </button>
                        </footer>
                    </article>

                    <article class="sponsor-card low-risk" aria-labelledby="gitonga-name">
                        <header class="sponsor-header">
                            <div class="sponsor-info">
                                <h4 class="sponsor-name" id="gitonga-name">Hon. Michael Gitonga</h4>
                                <p class="sponsor-role">Member of Parliament - Mombasa Central</p>
                            </div>
                            <div class="conflict-badge badge badge-success" aria-label="Low conflict risk assessment">Low Conflict Risk</div>
                        </header>

                        <section class="affiliations" aria-labelledby="gitonga-affiliations">
                            <h5 id="gitonga-affiliations">Known Affiliations</h5>
                            <div class="sponsor-affiliation">
                                <span class="affiliation-icon" aria-hidden="true">üè´</span>
                                <div class="affiliation-details">
                                    <strong>Public Health Institute</strong> - Former Research Fellow (2018-2022)
                                    <span class="badge badge-secondary">Minor COI</span>
                                </div>
                            </div>
                        </section>

                        <section class="financial-disclosure" aria-labelledby="gitonga-financial">
                            <h5 id="gitonga-financial">Financial Disclosure</h5>
                            <p>No significant healthcare-related financial interests reported in recent disclosure forms. Campaign funding primarily sourced from individual donors and civic organizations.</p>
                        </section>

                        <footer class="sponsor-actions">
                            <button class="btn-outline" type="button" aria-describedby="gitonga-analysis-desc">
                                View Detailed Analysis
                                <span id="gitonga-analysis-desc" class="sr-only">Complete analysis for Hon. Michael Gitonga</span>
                            </button>
                        </footer>
                    </article>
                </section>

                <section class="summary-analytics" aria-labelledby="risk-overview-heading">
                    <h3 id="risk-overview-heading">Conflict Risk Overview</h3>
                    <div class="analytics-grid" role="group" aria-labelledby="risk-overview-heading">
                        <div class="analytics-card high-risk" role="region" aria-labelledby="high-risk-count">
                            <span class="analytics-number" id="high-risk-count">4</span>
                            <span class="analytics-label">High Conflict Risk Sponsors</span>
                        </div>
                        <div class="analytics-card medium-risk" role="region" aria-labelledby="medium-risk-count">
                            <span class="analytics-number" id="medium-risk-count">6</span>
                            <span class="analytics-label">Medium Conflict Risk Sponsors</span>
                        </div>
                        <div class="analytics-card low-risk" role="region" aria-labelledby="low-risk-count">
                            <span class="analytics-number" id="low-risk-count">2</span>
                            <span class="analytics-label">Low Conflict Risk Sponsors</span>
                        </div>
                        <div class="analytics-card financial" role="region" aria-labelledby="financial-ties-total">
                            <span class="analytics-number" id="financial-ties-total">KSh 47.3M</span>
                            <span class="analytics-label">Total Industry Ties Value</span>
                        </div>
                    </div>
                </section>

                <section class="pattern-analysis" aria-labelledby="pattern-analysis-heading-1">
                    <h3 id="pattern-analysis-heading-1">
                        <span class="material-icons" aria-hidden="true">analytics</span>
                        Cross-Sponsor Pattern Analysis
                    </h3>
                    <div class="pattern-insights">
                        <article class="insight-item">
                            <span class="material-icons" aria-hidden="true">group_work</span>
                            <div class="insight-content">
                                <h4>Shared Corporate Connections</h4>
                                <p>Seven sponsors maintain direct or indirect ties to overlapping healthcare companies, indicating potential coordinated industry influence across legislative positions. These connections span pharmaceutical manufacturers, medical device companies, and healthcare service providers.</p>
                            </div>
                        </article>
                        <article class="insight-item">
                            <span class="material-icons" aria-hidden="true">account_balance</span>
                            <div class="insight-content">
                                <h4>Campaign Contribution Patterns</h4>
                                <p>Ten of twelve sponsors (83%) received campaign funding from companies that would be directly affected by this legislation, raising significant questions about potential conflicts of interest and the independence of legislative decision-making.</p>
                            </div>
                        </article>
                        <article class="insight-item">
                            <span class="material-icons" aria-hidden="true">timeline</span>
                            <div class="insight-content">
                                <h4>Investment Timing Concerns</h4>
                                <p>Five sponsors acquired healthcare investments within six months of bill introduction, suggesting possible advance knowledge of legislative priorities or strategic positioning to benefit from anticipated regulatory changes.</p>
                            </div>
                        </article>
                    </div>
                </section>

                <section class="detailed-profiles" aria-labelledby="detailed-profiles-heading">
                    <h3 id="detailed-profiles-heading">Detailed Sponsor Profiles</h3>

                    <article class="sponsor-card enhanced high-risk-profile" aria-labelledby="mutua-name">
                        <header class="sponsor-header">
                            <div class="sponsor-avatar" aria-hidden="true">SM</div>
                            <div class="sponsor-info">
                                <h4 class="sponsor-name" id="mutua-name">Hon. Sarah Mutua</h4>
                                <p class="sponsor-role">Member of Parliament - Western Region</p>
                                <p class="sponsor-committees">Health Committee (Member) | Budget Committee (Vice-Chair)</p>
                            </div>
                            <div class="conflict-badge badge badge-danger" aria-label="High conflict risk assessment">High Conflict Risk</div>
                        </header>

                        <div class="impact-summary">
                            <div class="impact-alert critical" role="alert" aria-labelledby="critical-conflict-heading">
                                <span class="material-icons" aria-hidden="true">error</span>
                                <div class="alert-content">
                                    <h5 id="critical-conflict-heading">Critical Conflict Identified</h5>
                                    <p>Current board position with company directly regulated by this legislation creates substantial conflict of interest requiring immediate attention and potential recusal consideration.</p>
                                </div>
                            </div>
                        </div>

                        <div class="sponsor-details">
                            <section class="detail-section" aria-labelledby="mutua-financial-heading">
                                <h5 id="mutua-financial-heading">
                                    <span class="material-icons" aria-hidden="true">monetization_on</span>
                                    Financial Interests &amp; Legislative Impact Analysis
                                </h5>
                                <div class="financial-breakdown">
                                    <article class="financial-item critical-conflict">
                                        <header class="financial-header">
                                            <h6 class="company-name">MediTech Innovations Ltd.</h6>
                                            <span class="badge badge-danger">Current Board Member</span>
                                            <span class="conflict-severity">DIRECT CONFLICT</span>
                                        </header>
                                        <div class="financial-details">
                                            <div class="financial-compensation">
                                                <h6>Annual Board Compensation</h6>
                                                <p>KSh 850,000 plus equity options valued at approximately KSh 300,000 annually</p>
                                            </div>
                                            <div class="bill-impact-analysis">
                                                <h6>Legislative Impact Assessment</h6>
                                                <p>Sections 12-15 of the National Healthcare Reform Act establish new medical device regulations that will directly affect MediTech's core product lines and market access. Favorable regulatory outcomes could significantly increase company valuation and board member compensation.</p>
                                            </div>
                                            <div class="timeline-concern">
                                                <span class="material-icons" aria-hidden="true">schedule</span>
                                                <div class="timing-details">
                                                    <h6>Timing Analysis</h6>
                                                    <p>Board appointment occurred three months before bill introduction, raising transparency concerns about advance knowledge of legislative priorities and potential for insider information advantage.</p>
                                                </div>
                                            </div>
                                        </div>
                                    </article>

                                    <article class="financial-item high-conflict">
                                        <header class="financial-header">
                                            <h6 class="company-name">Regional Healthcare Partners</h6>
                                            <span class="badge badge-danger">Major Investor (8% stake)</span>
                                        </header>
                                        <div class="financial-details">
                                            <div class="investment-value">
                                                <h6>Investment Details</h6>
                                                <p>KSh 1.8 million investment acquired September 2024, representing significant personal financial exposure</p>
                                            </div>
                                            <div class="bill-impact-analysis">
                                                <h6>Legislative Benefits Analysis</h6>
                                                <p>Healthcare infrastructure funding provisions in Sections 8-11 could substantially benefit regional healthcare partnerships through increased government contracts and expanded service opportunities, potentially doubling investment value.</p>
                                            </div>
                                        </div>
                                    </article>
                                </div>
                            </section>

                            <section class="detail-section" aria-labelledby="mutua-campaign-heading">
                                <h5 id="mutua-campaign-heading">
                                    <span class="material-icons" aria-hidden="true">campaign</span>
                                    Campaign Finance &amp; Industry Influence Analysis
                                </h5>
                                <div class="campaign-analysis">
                                    <div class="funding-overview">
                                        <h6>Healthcare Industry Contributions (Last Election Cycle)</h6>
                                        <p class="contribution-summary">
                                            <span class="contribution-amount">KSh 3.2 million</span>
                                            <span class="contribution-percentage">(68% of total campaign funding)</span>
                                        </p>
                                    </div>
                                    <div class="contributor-breakdown">
                                        <h6>Top Healthcare Industry Contributors</h6>
                                        <dl class="contributor-list">
                                            <div class="contributor-item">
                                                <dt class="contributor-name">Medical Device Manufacturing Association</dt>
                                                <dd class="contribution-amount">KSh 800,000</dd>
                                            </div>
                                            <div class="contributor-item">
                                                <dt class="contributor-name">Regional Healthcare Lobby</dt>
                                                <dd class="contribution-amount">KSh 650,000</dd>
                                            </div>
                                            <div class="contributor-item">
                                                <dt class="contributor-name">MediTech Political Action Committee</dt>
                                                <dd class="contribution-amount">KSh 400,000</dd>
                                            </div>
                                        </dl>
                                    </div>
                                </div>
                            </section>

                            <section class="detail-section" aria-labelledby="mutua-voting-heading">
                                <h5 id="mutua-voting-heading">
                                    <span class="material-icons" aria-hidden="true">how_to_vote</span>
                                    Historical Voting Pattern Analysis on Healthcare Issues
                                </h5>
                                <div class="voting-record">
                                    <div class="voting-alignment">
                                        <h6>Industry Alignment Score</h6>
                                        <p class="alignment-percentage">91% alignment with healthcare industry positions over past 3 years (21 of 23 relevant legislative votes)</p>
                                    </div>
                                    <div class="notable-votes">
                                        <h6>Key Legislative Positions</h6>
                                        <dl class="vote-history">
                                            <div class="vote-item">
                                                <dt class="vote-bill">Medical Device Safety Act (2024)</dt>
                                                <dd class="vote-position">Voted against stronger safety requirements and independent oversight provisions</dd>
                                                <dd class="industry-alignment">Position directly aligned with MediTech corporate lobbying efforts and board recommendations</dd>
                                            </div>
                                            <div class="vote-item">
                                                <dt class="vote-bill">Healthcare Price Transparency Bill (2023)</dt>
                                                <dd class="vote-position">Voted against public pricing disclosure requirements for healthcare services</dd>
                                                <dd class="industry-alignment">Position aligned with Regional Healthcare Partners' business model and profit margins</dd>
                                            </div>
                                        </dl>
                                    </div>
                                </div>
                            </section>
                        </div>

                        <section class="accountability-actions" aria-labelledby="mutua-actions-heading">
                            <h5 id="mutua-actions-heading">Recommended Accountability Actions</h5>
                            <dl class="action-items">
                                <div class="action-item urgent">
                                    <div class="action-visual">
                                        <span class="material-icons" aria-hidden="true">gavel</span>
                                        <div class="priority-indicator"></div>
                                    </div>
                                    <dt>
                                        Recusal Recommended
                                        <span class="action-timer">
                                            <span class="material-icons">schedule</span>
                                            Recommended within 48hrs
                                        </span>
                                    </dt>
                                    <dd>Given direct financial conflict through board membership and investment holdings, recusal from final vote is strongly recommended to maintain legislative integrity and public trust.</dd>
                                </div>
                                <div class="action-item">
                                    <dt>
                                        <span class="material-icons" aria-hidden="true">visibility</span>
                                        Enhanced Disclosure Required
                                    </dt>
                                    <dd>Public disclosure of all board meeting discussions, voting records, and compensation details related to this legislation should be provided for full transparency and accountability.</dd>
                                </div>
                            </dl>
                        </section>

                        <footer class="sponsor-actions">
                            <button class="btn-outline enhanced" type="button" aria-describedby="mutua-complete-analysis">
                                View Complete Conflict Analysis Report
                                <span id="mutua-complete-analysis" class="sr-only">Comprehensive conflict analysis report for Hon. Sarah Mutua</span>
                            </button>
                        </footer>
                    </article>

                    <article class="sponsor-card enhanced low-risk-profile" aria-labelledby="kamau-name">
                        <header class="sponsor-header">
                            <div class="sponsor-avatar" aria-hidden="true">JK</div>
                            <div class="sponsor-info">
                                <h4 class="sponsor-name" id="kamau-name">Hon. John Kamau</h4>
                                <p class="sponsor-role">Member of Parliament - Central District</p>
                                <p class="sponsor-committees">Education Committee (Chair) | Health Committee (Member)</p>
                            </div>
                            <div class="conflict-badge badge badge-success" aria-label="Low conflict risk assessment">Low Conflict Risk</div>
                        </header>

                        <div class="transparency-highlights">
                            <div class="highlight-item">
                                <span class="material-icons" aria-hidden="true">verified</span>
                                <span>Clean Financial Disclosure Record</span>
                            </div>
                            <div class="highlight-item">
                                <span class="material-icons" aria-hidden="true">balance</span>
                                <span>Consistent Public Interest Voting History</span>
                            </div>
                        </div>

                        <div class="sponsor-details">
                            <section class="detail-section" aria-labelledby="kamau-background-heading">
                                <h5 id="kamau-background-heading">
                                    <span class="material-icons" aria-hidden="true">business</span>
                                    Professional Background &amp; Relevant Experience
                                </h5>
                                <div class="professional-background">
                                    <article class="affiliation-item no-conflict">
                                        <header class="affiliation-header">
                                            <h6 class="affiliation-name">National Medical Research Institute</h6>
                                            <span class="badge badge-primary">Former Researcher (2015-2019)</span>
                                        </header>
                                        <div class="affiliation-details">
                                            <p class="role-description">Led academic research initiatives in public health policy development and healthcare accessibility studies</p>
                                            <p class="conflict-assessment">No current financial interest, ongoing relationship, or consulting arrangements</p>
                                            <p class="expertise-value">Research experience provides valuable technical expertise for healthcare legislation evaluation without creating financial conflicts of interest or compromise of independent judgment.</p>
                                        </div>
                                    </article>
                                </div>
                            </section>

                            <section class="detail-section" aria-labelledby="kamau-independence-heading">
                                <h5 id="kamau-independence-heading">
                                    <span class="material-icons" aria-hidden="true">verified_user</span>
                                    Independence Verification Analysis
                                </h5>
                                <div class="independence-assessment">
                                    <dl class="independence-checklist">
                                        <div class="check-item verified">
                                            <dt>
                                                <span class="material-icons" aria-hidden="true">check_circle</span>
                                                Healthcare Industry Financial Interests
                                            </dt>
                                            <dd>No current healthcare industry investments, stock holdings, or financial interests identified in comprehensive disclosure review</dd>
                                        </div>
                                        <div class="check-item verified">
                                            <dt>
                                                <span class="material-icons" aria-hidden="true">check_circle</span>
                                                Family Member Employment
                                            </dt>
                                            <dd>No immediate family members employed in healthcare industries that would be affected by this legislation</dd>
                                        </div>
                                        <div class="check-item verified">
                                            <dt>
                                                <span class="material-icons" aria-hidden="true">check_circle</span>
                                                Campaign Funding Sources
                                            </dt>
                                            <dd>Campaign funding primarily from individual donors (78% of total contributions), with minimal corporate healthcare industry contributions</dd>
                                        </div>
                                        <div class="check-item verified">
                                            <dt>
                                                <span class="material-icons" aria-hidden="true">check_circle</span>
                                                Legislative Voting Independence
                                            </dt>
                                            <dd>Voting record demonstrates consistent independence from industry lobbying influence, prioritizing public health outcomes</dd>
                                        </div>
                                    </dl>
                                </div>
                            </section>
                        </div>

                        <div class="clean-record-summary">
                            <span class="material-icons" aria-hidden="true">thumb_up</span>
                            <div class="summary-content">
                                <h5>Transparency Assessment Summary</h5>
                                <p>Comprehensive analysis reveals no significant conflicts of interest. This sponsor demonstrates strong commitment to public interest representation and maintains exemplary transparent governance practices throughout their legislative service. Independent decision-making capability verified.</p>
                            </div>
                        </div>

                        <footer class="sponsor-actions">
                            <button class="btn-outline" type="button" aria-describedby="kamau-verification-report">
                                View Complete Independence Verification
                                <span id="kamau-verification-report" class="sr-only">Complete independence verification report for Hon. John Kamau</span>
                            </button>
                        </footer>
                    </article>
                </section>
            </main>

            <!-- Conflict Analysis Panel -->
            <div class="subpanel" id="co-sponsors-analysis" role="tabpanel" aria-labelledby="analysis-tab">
                <header class="analysis-header">
                    <h2>Co-Sponsors Conflict Analysis</h2>
                    <p class="analysis-description">Detailed conflict of interest analysis for all co-sponsors, examining financial relationships, voting patterns, and potential legislative benefits.</p>
                    <div class="progressive-disclosure-controls">
                        <button class="btn-disclosure" data-target="conflict-summary">Summary View</button>
                        <button class="btn-disclosure" data-target="detailed-conflicts">Detailed Analysis</button>
                        <button class="btn-disclosure" data-target="recommendations">Action Recommendations</button>
                    </div>
                </header>

                <section class="conflict-summary" aria-labelledby="conflict-summary-heading">
                    <h3 id="conflict-summary-heading">Aggregate Conflict Assessment</h3>
                    <div class="conflict-metrics">
                    <div class="metric-card critical">
                        <div class="metric-visual">
                            <span class="metric-number">4</span>
                            <div class="risk-meter">
                                <div class="risk-fill" style="width: 100%"></div>
                            </div>
                        </div>
                        <span class="metric-label">Critical Conflicts</span>
                        <p>Direct financial benefits exceeding KSh 1M</p>
                        <button class="info-tooltip" aria-label="More info">
                            <span class="material-icons">info</span>
                        </button>
                    </div>
                        <div class="metric-card high">
                            <span class="metric-number">6</span>
                            <span class="metric-label">High Risk</span>
                            <p>Significant industry relationships</p>
                        </div>
                        <div class="metric-card medium">
                            <span class="metric-number">2</span>
                            <span class="metric-label">Medium Risk</span>
                            <p>Minor conflicts requiring disclosure</p>
                        </div>
                    </div>
                </section>

                <section class="detailed-conflicts" aria-labelledby="detailed-conflicts-heading">
                    <h3 id="detailed-conflicts-heading">Individual Conflict Assessments</h3>
                    <div class="conflicts-list">
                        <article class="conflict-item critical">
                            <header class="conflict-header">
                                <h4>Hon. Sarah Mutua - Critical Conflict</h4>
                                <span class="badge badge-danger">Recusal Recommended</span>
                            </header>
                            <div class="conflict-details">
                                <div class="conflict-header">
                                    <h5>Primary Conflict</h5>
                                    <span class="confidence-rating">
                                        <span class="material-icons">verified</span>
                                        98% Confidence
                                    </span>
                                </div>
                                <p>Board member of MediTech Innovations, directly regulated by Sections 12-15</p>
                                <p><strong>Financial Exposure:</strong> KSh 2.65M in direct compensation and investments</p>
                                <p><strong>Recommendation:</strong> Immediate recusal from voting and committee deliberations</p>
                            </div>
                        </article>

                        <article class="conflict-item high">
                            <header class="conflict-header">
                                <h4>Hon. Sarah Odhiambo - High Risk</h4>
                                <span class="badge badge-warning">Enhanced Disclosure Required</span>
                            </header>
                            <div class="conflict-details">
                                <p><strong>Primary Conflict:</strong> National Healthcare Alliance board position</p>
                                <p><strong>Financial Exposure:</strong> KSh 2.8M in campaign contributions from affected entities</p>
                                <p><strong>Recommendation:</strong> Public disclosure of all board discussions related to legislation</p>
                            </div>
                        </article>
                    </div>
                </section>
            </div>

            <!-- Voting Patterns Panel -->
            <div class="subpanel" id="co-sponsors-patterns" role="tabpanel" aria-labelledby="patterns-tab">
                <header class="patterns-header">
                    <h2>Co-Sponsors Voting Pattern Analysis</h2>
                    <p class="patterns-description">Analysis of historical voting patterns on healthcare-related legislation to identify potential industry influence trends.</p>
                    <div class="disclosure-level-selector">
                        <label for="pattern-disclosure-level">Disclosure Level:</label>
                        <select class="form-control" id="pattern-disclosure-level" title="Select disclosure level" aria-label="Select disclosure level">
                            <option value="summary">Summary View</option>
                            <option value="intermediate">Key Insights</option>
                            <option value="detailed">Full Analysis</option>
                        </select>
                    </div>
                </header>

                <section class="voting-trends" aria-labelledby="voting-trends-heading-1">
                    <h3 id="voting-trends-heading-1">Industry Alignment Trends</h3>
                    <div class="trends-overview">
                        <div class="trend-metric">
                            <span class="trend-percentage">73%</span>
                            <span class="trend-label">Average Industry Alignment</span>
                            <p>Across all co-sponsors on healthcare votes (2022-2024)</p>
                        </div>
                        <div class="trend-metric">
                            <span class="trend-percentage">89%</span>
                            <span class="trend-label">High-Conflict Sponsors Alignment</span>
                            <p>Sponsors with significant financial interests</p>
                        </div>
                    </div>
                </section>

                <section class="pattern-analysis" aria-labelledby="pattern-analysis-heading-2">
                    <h3 id="pattern-analysis-heading-2">Key Voting Pattern Insights</h3>
                    <div class="pattern-insights">
                        <article class="insight-card">
                            <h4>Coordinated Voting Behavior</h4>
                            <p>Seven co-sponsors consistently vote together on healthcare legislation (94% alignment), suggesting potential coordination or shared influence sources.</p>
                        </article>

                        <article class="insight-card">
                            <h4>Industry Position Correlation</h4>
                            <p>Co-sponsors with healthcare industry financial ties vote in alignment with industry positions 91% of the time, compared to 45% for sponsors without such ties.</p>
                        </article>

                        <article class="insight-card">
                            <h4>Timing Anomalies</h4>
                            <p>Five co-sponsors changed their typical voting patterns on healthcare issues within 6 months of receiving significant industry contributions.</p>
                        </article>
                    </div>
                </section>
            </div>

            <!-- Individual Details Panel -->
            <div class="subpanel" id="co-sponsors-details" role="tabpanel" aria-labelledby="details-tab">
                    <div class="accordion-controls">
                        <button class="btn-accordion" data-action="expand-all">Expand All</button>
                        <button class="btn-accordion" data-action="collapse-all">Collapse All</button>
                    </div>
                <header class="details-header">
                    <h2>Individual Co-Sponsor Detailed Profiles</h2>
                    <p class="details-description">Comprehensive profiles of each co-sponsor including financial disclosures, professional background, and legislative history.</p>
                </header>

                <section class="sponsor-directory" aria-labelledby="sponsor-directory-heading">
                    <h3 id="sponsor-directory-heading">Complete Co-Sponsor Directory</h3>
                    <div class="directory-filters">
                        <button class="filter-btn active" data-filter="all">All Sponsors (12)</button>
                        <button class="filter-btn" data-filter="high-risk">High Risk (4)</button>
                        <button class="filter-btn" data-filter="medium-risk">Medium Risk (6)</button>
                        <button class="filter-btn" data-filter="low-risk">Low Risk (2)</button>
                    </div>

                    <div class="sponsors-grid">
                        <article class="sponsor-detail-card high-risk" data-category="high-risk">
                            <header class="sponsor-card-header">
                                <div class="sponsor-avatar">SM</div>
                                <div class="sponsor-basic-info">
                                    <h4>Hon. Sarah Mutua</h4>
                                    <p>Western Region MP</p>
                                    <span class="risk-badge badge-danger">Critical Risk</span>
                                </div>
                            </header>
                            <div class="sponsor-quick-stats">
                                <div class="stat-item">
                                    <span class="stat-label">Financial Exposure:</span>
                                    <span class="stat-value">KSh 2.65M</span>
                                </div>
                                <div class="stat-item">
                                    <span class="stat-label">Industry Alignment:</span>
                                    <span class="stat-value">91%</span>
                                </div>
                                <div class="stat-item">
                                    <span class="stat-label">Board Positions:</span>
                                    <span class="stat-value">2 Active</span>
                                </div>
                            </div>
                            <footer class="sponsor-card-actions">
                                <button class="btn-outline">View Full Profile</button>
                                <button class="btn-secondary">Download Report</button>
                            </footer>
                        </article>

                        <article class="sponsor-detail-card low-risk" data-category="low-risk">
                            <header class="sponsor-card-header">
                                <div class="sponsor-avatar">JK</div>
                                <div class="sponsor-basic-info">
                                    <h4>Hon. John Kamau</h4>
                                    <p>Central District MP</p>
                                    <span class="risk-badge badge-success">Low Risk</span>
                                </div>
                            </header>
                            <div class="sponsor-quick-stats">
                                <div class="stat-item">
                                    <span class="stat-label">Financial Exposure:</span>
                                    <span class="stat-value">KSh 0</span>
                                </div>
                                <div class="stat-item">
                                    <span class="stat-label">Industry Alignment:</span>
                                    <span class="stat-value">47%</span>
                                </div>
                                <div class="stat-item">
                                    <span class="stat-label">Board Positions:</span>
                                    <span class="stat-value">0 Active</span>
                                </div>
                            </div>
                            <footer class="sponsor-card-actions">
                                <button class="btn-outline">View Full Profile</button>
                                <button class="btn-secondary">Download Report</button>
                            </footer>
                        </article>

                        <!-- Additional sponsor cards would be added here -->
                        <div class="sponsor-placeholder">
                            <p>Additional co-sponsor profiles (10 more) would be displayed here with similar detailed information including financial disclosures, voting histories, and conflict assessments.</p>
                        </div>
                    </div>
                </section>
            </div>
        </div>
    </div>

      <div class="tab-content" id="financial-backers">
        <div class="subtabs-container" id="financial-backers-subtabs">
            <div class="subtabs" role="tablist">
                <button class="subtab is-active" role="tab" aria-controls="backers-overview">Overview</button>
                <button class="subtab" role="tab" aria-controls="backers-corporate">Corporate Backers</button>
                <button class="subtab" role="tab" aria-controls="backers-industry">Industry Analysis</button>
                <button class="subtab" role="tab" aria-controls="backers-influence">Influence Mapping</button>
            </div>

            <div class="subpanel is-active" id="backers-overview">
                <h3>Financial Backers Analysis</h3>
                <p>Comprehensive analysis of financial contributions and support for the National Healthcare Reform Act.</p>
                <div class="backers-summary">
                    <div class="summary-card">
                        <h4>Total Financial Support</h4>
                        <div class="amount">KSh 142.8M</div>
                        <p>Combined contributions from all identified sources</p>
                    </div>
                    <div class="summary-card">
                        <h4>Primary Industry Sources</h4>
                        <div class="percentage">68%</div>
                        <p>Healthcare and pharmaceutical sector contributions</p>
                    </div>
                    <div class="summary-card">
                        <h4>Transparency Rating</h4>
                        <div class="rating">Medium</div>
                        <p>Based on disclosure completeness and verification</p>
                    </div>
                </div>

                <div class="quick-insights">
                    <h4>Key Financial Patterns</h4>
                    <div class="insight-grid">
                        <div class="insight-item">
                            <span class="material-icons">trending_up</span>
                            <div class="insight-content">
                                <strong>Contribution Timing</strong>
                                <p>83% of major contributions occurred within 90 days of bill introduction</p>
                            </div>
                        </div>
                        <div class="insight-item">
                            <span class="material-icons">business</span>
                            <div class="insight-content">
                                <strong>Corporate Concentration</strong>
                                <p>Top 5 entities account for 74% of total financial backing</p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="subpanel" id="backers-corporate">
                <h3>Key Corporate Backers</h3>
                <p>Analysis of major corporate entities providing financial support to bill sponsors.</p>
                <div class="corporate-backers-list">
                    <div class="backer-card high-influence">
                        <div class="backer-header">
                            <h4>East African Pharmaceuticals</h4>
                            <div class="badge badge-danger">High Influence</div>
                        </div>
                        <div class="contribution-amount">KSh 42.3M</div>
                        <p>Primary manufacturer of medications affected by pricing provisions in Sections 4-7</p>
                        <div class="influence-metrics">
                            <div class="metric">
                                <span class="metric-label">Lobbying Expenditure:</span>
                                <span class="metric-value">KSh 12.7M (2024)</span>
                            </div>
                            <div class="metric">
                                <span class="metric-label">Sponsored Events:</span>
                                <span class="metric-value">7 legislative forums</span>
                            </div>
                            <div class="metric">
                                <span class="metric-label">Bill Sections Affected:</span>
                                <span class="metric-value">Sections 4-7, 12-14</span>
                            </div>
                        </div>
                    </div>

                    <div class="backer-card medium-influence">
                        <div class="backer-header">
                            <h4>National Healthcare Alliance</h4>
                            <div class="badge badge-warning">Medium Influence</div>
                        </div>
                        <div class="contribution-amount">KSh 28.5M</div>
                        <p>Industry association representing 24 healthcare providers affected by Sections 12-14</p>
                        <div class="influence-metrics">
                            <div class="metric">
                                <span class="metric-label">Policy Papers:</span>
                                <span class="metric-value">3 position documents</span>
                            </div>
                            <div class="metric">
                                <span class="metric-label">Legislative Meetings:</span>
                                <span class="metric-value">12 documented sessions</span>
                            </div>
                            <div class="metric">
                                <span class="metric-label">Member Organizations:</span>
                                <span class="metric-value">24 healthcare providers</span>
                            </div>
                        </div>
                    </div>

                    <div class="backer-card low-influence">
                        <div class="backer-header">
                            <h4>Medical Innovation Fund</h4>
                            <div class="badge badge-info">Moderate Influence</div>
                        </div>
                        <div class="contribution-amount">KSh 18.7M</div>
                        <p>Investment fund focused on healthcare technology startups and medical device companies</p>
                        <div class="influence-metrics">
                            <div class="metric">
                                <span class="metric-label">Portfolio Companies:</span>
                                <span class="metric-value">12 affected entities</span>
                            </div>
                            <div class="metric">
                                <span class="metric-label">Research Grants:</span>
                                <span class="metric-value">KSh 4.2M distributed</span>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="subpanel" id="backers-industry">
                <h3>Industry Lobbying Activity</h3>
                <p>Breakdown of industry-specific lobbying efforts related to this legislation.</p>
                <div class="industry-analysis">
                    <div class="industry-chart">
                        <div class="chart-placeholder">Industry Contribution Distribution Chart</div>
                    </div>
                    <div class="industry-breakdown">
                        <h4>Key Industry Sectors</h4>
                        <div class="industry-item">
                            <div class="industry-name">Pharmaceutical Manufacturing</div>
                            <div class="industry-bar">
                                <div class="bar-fill" style="width: 42%;"></div>
                                <span>42%</span>
                            </div>
                            <div class="industry-amount">KSh 60.1M</div>
                        </div>
                        <div class="industry-item">
                            <div class="industry-name">Hospital Management Groups</div>
                            <div class="industry-bar">
                                <div class="bar-fill" style="width: 26%;"></div>
                                <span>26%</span>
                            </div>
                            <div class="industry-amount">KSh 37.2M</div>
                        </div>
                        <div class="industry-item">
                            <div class="industry-name">Medical Technology</div>
                            <div class="industry-bar">
                                <div class="bar-fill" style="width: 18%;"></div>
                                <span>18%</span>
                            </div>
                            <div class="industry-amount">KSh 25.7M</div>
                        </div>
                        <div class="industry-item">
                            <div class="industry-name">Insurance Providers</div>
                            <div class="industry-bar">
                                <div class="bar-fill" style="width: 14%;"></div>
                                <span>14%</span>
                            </div>
                            <div class="industry-amount">KSh 19.9M</div>
                        </div>
                    </div>
                </div>
            </div>

            <div class="subpanel" id="backers-influence">
                <h3>Influence Mapping & Network Analysis</h3>
                <p>Visual representation of financial relationships and influence networks affecting this legislation.</p>
                <div class="influence-network">
                    <div class="network-visualization">
                        <div class="chart-placeholder">Interactive Influence Network Diagram</div>
                        <p class="chart-description">This network shows connections between financial backers, bill sponsors, and affected industries. Node size represents financial contribution amount, while connection thickness indicates relationship strength.</p>
                    </div>

                    <div class="influence-metrics">
                        <h4>Network Analysis Results</h4>
                        <div class="metrics-grid">
                            <div class="metric-card">
                                <span class="metric-value">23</span>
                                <span class="metric-label">Connected Entities</span>
                            </div>
                            <div class="metric-card">
                                <span class="metric-value">67%</span>
                                <span class="metric-label">Interconnection Rate</span>
                            </div>
                            <div class="metric-card">
                                <span class="metric-value">8</span>
                                <span class="metric-label">Key Influence Nodes</span>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
      </div>

    <div class="tab-content" id="methodology">
        <div class="subtabs-container" id="methodology-subtabs">
            <h2 style="margin-top:0">Intelligence & Methodology</h2>
            <div class="subtabs" role="tablist">
        <button class="subtab is-active" role="tab" aria-controls="sub-methodology" id="sub-methodology-btn">Analysis Framework</button>
        <button class="subtab" role="tab" aria-controls="sub-collection" id="sub-collection-btn">Data Collection</button>
        <button class="subtab" role="tab" aria-controls="sub-weighting" id="sub-weighting-btn">Verification & Weighting</button>
        <button class="subtab" role="tab" aria-controls="sub-assessment" id="sub-assessment-btn">Risk Assessment</button>
        <button class="subtab" role="tab" aria-controls="sub-public" id="sub-public-btn">Public Oversight</button>
        <button class="subtab" role="tab" aria-controls="sub-ai" id="sub-ai-btn">AI-Enhanced Analysis</button>
    </div>

    <!-- Analysis Framework Panel -->
    <div class="subpanel is-active" id="sub-methodology" role="tabpanel" aria-labelledby="sub-methodology-btn">
        <div class="methodology-section">
            <h3 class="methodology-title">
                <span class="material-icons">science</span>
                Our Comprehensive Analysis Framework
            </h3>
            <p class="intro-text">Chanuka employs a systematic, multi-layered approach to analyze potential conflicts of interest and external influences on legislation. Our methodology combines quantitative data analysis with qualitative assessment to provide transparent, evidence-based evaluations of legislative integrity.</p>

            <div class="methodology-overview">
                <h4>Five-Stage Analysis Process</h4>
                <p>Each legislative proposal undergoes rigorous examination through our structured five-stage process, ensuring comprehensive coverage of potential conflicts while maintaining analytical objectivity. This systematic approach allows us to identify patterns and connections that might otherwise remain hidden from public view.</p>

                <div class="process-stages">
                    <div class="stage-card">
                        <div class="stage-number">1</div>
                        <h5>Official Records Foundation</h5>
                        <p>Systematic compilation of verifiable government data including financial disclosures, committee assignments, and voting histories to establish documented baseline connections.</p>
                    </div>

                    <div class="stage-card">
                        <div class="stage-number">2</div>
                        <h5>Financial Influence Mapping</h5>
                        <p>Advanced tracking of campaign contributions and financial relationships across multiple election cycles to identify potential monetary influences on policy positions.</p>
                    </div>

                    <div class="stage-card">
                        <div class="stage-number">3</div>
                        <h5>Content Origin Analysis</h5>
                        <p>Natural language processing comparison of bill text with industry publications and lobbying materials to detect external authorship indicators.</p>
                    </div>

                    <div class="stage-card">
                        <div class="stage-number">4</div>
                        <h5>Intelligence Integration</h5>
                        <p>Incorporation of verified open source intelligence from credible media, academic research, and civil society investigations to provide crucial context.</p>
                    </div>

                    <div class="stage-card">
                        <div class="stage-number">5</div>
                        <h5>Synthesis & Scoring</h5>
                        <p>Proprietary algorithm combines all data points to generate nuanced conflict risk scores, factoring connection strength and contextual relevance.</p>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- Data Collection Panel -->
    <div class="subpanel" id="sub-collection" role="tabpanel" aria-labelledby="sub-collection-btn">
        <h3>Advanced Data Collection Infrastructure</h3>
        <p>Our comprehensive data collection system operates continuously to maintain current and accurate information about legislative conflicts of interest. Multiple automated and expert-verified channels ensure comprehensive coverage of relevant information sources.</p>

        <div class="collection-methods">
            <div class="method-card">
                <h4>Automated Public Records Scraper</h4>
                <p>Systematically monitors financial disclosures, property records, business registrations, and other official government databases across federal, state, and local levels. Updates occur daily with cross-referencing capabilities across 34 jurisdictions.</p>
                <div class="capability-stats">Coverage: 1.2M+ entities | Update frequency: Daily | Accuracy rate: 98.7%</div>
            </div>

            <div class="method-card">
                <h4>Corporate Relationship Graph Engine</h4>
                <p>Maps complex corporate ownership structures, subsidiary relationships, and business partnerships to identify indirect financial connections that may not be apparent in surface-level disclosures.</p>
                <div class="capability-stats">Entities tracked: 1.2M+ companies | Relationship depth: 5 degrees | Jurisdictions: 34</div>
            </div>

            <div class="method-card">
                <h4>Media Intelligence Monitor</h4>
                <p>Natural language processing analysis of 300+ news outlets, trade publications, and investigative reports to identify emerging conflicts and verify reported connections through sentiment analysis and fact verification.</p>
                <div class="capability-stats">Sources monitored: 300+ outlets | Processing: Real-time | Languages: 12</div>
            </div>

            <div class="method-card">
                <h4>Expert Verification Network</h4>
                <p>42 sector specialists across industries including healthcare, finance, technology, and energy provide peer review and cross-checking of flagged data points to ensure accuracy and context.</p>
                <div class="capability-stats">Expert reviewers: 42 specialists | Response time: 48 hours | Verification rate: 94.2%</div>
            </div>
        </div>
    </div>

    <!-- Verification & Weighting Panel -->
    <div class="subpanel" id="sub-weighting" role="tabpanel" aria-labelledby="sub-weighting-btn">
        <h3>Information Verification & Weighting Framework</h3>
        <p>Our sophisticated weighting system ensures that information about potential conflicts of interest receives appropriate consideration based on reliability, verifiability, and relevance. This multi-dimensional approach prevents both false positives and missed connections.</p>

        <div class="weighting-system">
            <h4>Source Credibility Assessment</h4>
            <div class="credibility-factors">
                <div class="weighting-factor">
                    <div class="factor-header">
                        <div class="weighting-factor-name">Documentary Evidence Support</div>
                        <div class="weight-value">35%</div>
                    </div>
                    <p>Information backed by official documents, recorded communications, or verified transactions receives the highest weighting. Documentary evidence provides the strongest foundation for conflict assessments.</p>
                    <label for="documentary-evidence-slider" class="sr-only">Documentary Evidence Weighting</label>
<input type="range" id="documentary-evidence-slider" class="weighting-slider" min="0" max="100" value="95" disabled aria-labelledby="documentary-evidence-label">
                </div>

                <div class="weighting-factor">
                    <div class="factor-header">
                        <div class="weighting-factor-name">Independent Verification Status</div>
                        <div class="weight-value">25%</div>
                    </div>
                    <p>Information independently verified through multiple unrelated sources receives enhanced weighting. Cross-verification strengthens reliability and reduces misinformation risk.</p>
                    <label for="verification-status-slider" class="sr-only">Independent Verification Weighting</label>
<input type="range" id="verification-status-slider" class="weighting-slider" min="0" max="100" value="85" disabled aria-labelledby="verification-status-label">
                </div>

                <div class="weighting-factor">
                    <div class="factor-header">
                        <div class="weighting-factor-name">Source Reputation Scoring</div>
                        <div class="weight-value">20%</div>
                    </div>
                    <p>Established track record and credibility of information sources influences weighting. Verified, reputable sources receive significantly higher consideration than questionable sources.</p>
                    <label for="source-reputation-slider" class="sr-only">Source Reputation Weighting</label>
<input type="range" id="source-reputation-slider" class="weighting-slider" min="0" max="100" value="90" disabled aria-labelledby="source-reputation-label">
                </div>

                <div class="weighting-factor">
                    <div class="factor-header">
                        <div class="weighting-factor-name">Temporal Relevance</div>
                        <div class="weight-value">20%</div>
                    </div>
                    <p>Recent information receives higher weighting with exponential decay over time. Current relationships and recent activities have appropriate influence on assessments.</p>
                    <label for="temporal-relevance-slider" class="sr-only">Temporal Relevance Weighting</label>
<input type="range" id="temporal-relevance-slider" class="weighting-slider" min="0" max="100" value="70" disabled aria-labelledby="temporal-relevance-label">
                </div>
            </div>

            <div class="model-controls">
                <h4>Analysis Sensitivity Controls</h4>
                <p>Transparency extends to our analytical parameters. Users can understand how sensitivity adjustments affect conflict detection thresholds, ensuring our methodology remains open to scrutiny.</p>
                <label for="modelSensitivity">Detection Sensitivity Level (Current: High)</label>
                <input type="range" id="modelSensitivity" min="50" max="100" value="90" style="width:100%" disabled>
                <div class="sensitivity-description">Higher sensitivity captures more potential conflicts but may increase false positives. Lower sensitivity focuses on stronger connections but may miss subtle influences.</div>
            </div>
        </div>
    </div>

    <!-- Risk Assessment Panel -->
    <div class="subpanel" id="sub-assessment" role="tabpanel" aria-labelledby="sub-assessment-btn">
        <h3>Conflict Risk Assessment Dimensions</h3>
        <p>Our comprehensive assessment evaluates multiple dimensions of potential conflicts, providing nuanced understanding rather than simplistic binary judgments. Each dimension contributes to an overall transparency score that reflects the complexity of modern legislative processes.</p>

        <div class="assessment-dimensions">
            <div class="dimension-card">
                <h4>Financial Interest Analysis</h4>
                <div class="meter-container">
                    <div class="meter"><span class="high" style="width: 80%"></span></div>
                    <div class="meter-label">Weight: 35%</div>
                </div>
                <p>Measures scope and significance of direct or indirect financial benefits a sponsor may receive from proposed legislation, including immediate gains and long-term financial implications across family members and associated entities.</p>
                <div class="sub-metrics">
                    <span class="metric-tag">Direct Holdings</span>
                    <span class="metric-tag">Family Interests</span>
                    <span class="metric-tag">Future Benefits</span>
                </div>
            </div>

            <div class="dimension-card">
                <h4>Relational Proximity Assessment</h4>
                <div class="meter-container">
                    <div class="meter"><span class="medium" style="width: 60%"></span></div>
                    <div class="meter-label">Weight: 25%</div>
                </div>
                <p>Evaluates closeness and nature of relationships between legislative sponsors and entities benefiting from proposed legislation, considering professional networks, personal connections, and historical collaboration patterns.</p>
                <div class="sub-metrics">
                    <span class="metric-tag">Professional Ties</span>
                    <span class="metric-tag">Board Positions</span>
                    <span class="metric-tag">Advisory Roles</span>
                </div>
            </div>

            <div class="dimension-card">
                <h4>Disclosure Transparency</h4>
                <div class="meter-container">
                    <div class="meter"><span class="low" style="width: 40%"></span></div>
                    <div class="meter-label">Weight: 20%</div>
                </div>
                <p>Assesses completeness and timeliness of official disclosures, identifying gaps or delays that may indicate attempts to obscure potential conflicts or inadequate transparency practices.</p>
                <div class="sub-metrics">
                    <span class="metric-tag">Filing Timeliness</span>
                    <span class="metric-tag">Information Completeness</span>
                    <span class="metric-tag">Update Frequency</span>
                </div>
            </div>

            <div class="dimension-card">
                <h4>Legislative Influence Scope</h4>
                <div class="meter-container">
                    <div class="meter"><span class="medium" style="width: 55%"></span></div>
                    <div class="meter-label">Weight: 20%</div>
                </div>
                <p>Measures the sponsor's ability to shape specific clauses, amendments, or implementation details that directly benefit their interests, including committee positions and historical success in advancing similar legislation.</p>
                <div class="sub-metrics">
                    <span class="metric-tag">Committee Power</span>
                    <span class="metric-tag">Amendment Influence</span>
                    <span class="metric-tag">Implementation Control</span>
                </div>
            </div>
        </div>
    </div>

    <!-- Public Oversight Panel -->
    <div class="subpanel" id="sub-public" role="tabpanel" aria-labelledby="sub-public-btn">
        <h3>Public Submission & Oversight Portal</h3>
        <p>Democratic transparency requires public participation. Citizens, journalists, and watchdog organizations can contribute verified information about potential conflicts, creating a collaborative approach to legislative oversight that extends beyond automated systems.</p>

        <div class="submission-stats">
            <div class="stat-card">
                <div class="stat-number">847</div>
                <div class="stat-label">Submissions This Month</div>
            </div>
            <div class="stat-card">
                <div class="stat-number">94.2%</div>
                <div class="stat-label">Verification Rate</div>
            </div>
            <div class="stat-card">
                <div class="stat-number">23</div>
                <div class="stat-label">New Conflicts Identified</div>
            </div>
        </div>

        <form class="submission-form" data-endpoint="/api/submissions">
            <div class="form-section">
                <h4>Submit Conflict Information</h4>
                <p>All submissions undergo verification through our expert network before inclusion in assessments. Verified contributors receive recognition in our public database.</p>
            </div>

            <div class="form-row">
                <div class="form-field">
                    <label for="psName">Legislative Sponsor</label>
                    <input id="psName" required placeholder="Representative/Senator name">
                </div>
                <div class="form-field">
                    <label for="psBill">Related Legislation</label>
                    <input id="psBill" placeholder="Bill number or title">
                </div>
            </div>

            <div class="form-field">
                <label for="psType">Information Category</label>
                <select id="psType" required>
                    <option value="">Select category‚Ä¶</option>
                    <option>Financial Interest</option>
                    <option>Corporate Affiliation</option>
                    <option>Family Connection</option>
                    <option>Undisclosed Relationship</option>
                    <option>Lobbying Contact</option>
                    <option>Other Conflict</option>
                </select>
            </div>

            <div class="form-field">
                <label for="psDetails">Detailed Description</label>
                <textarea id="psDetails" rows="4" required placeholder="Provide specific details about the potential conflict, including dates, amounts, and relationships"></textarea>
            </div>

            <div class="form-field">
                <label for="psEvidence">Supporting Evidence</label>
                <textarea id="psEvidence" rows="3" placeholder="URLs to documents, news reports, or other verifiable sources (one per line)"></textarea>
                <div class="field-help">Evidence sources help our verification team confirm submissions more quickly</div>
            </div>

            <div class="form-field">
                <label for="psContact">Contact Information (Optional)</label>
                <input id="psContact" type="email" placeholder="email@example.com">
                <div class="field-help">For follow-up questions during verification process</div>
            </div>

            <div class="form-actions">
                <button type="submit" class="btn-primary">Submit for Verification</button>
                <button type="reset" class="btn-secondary">Clear Form</button>
            </div>
        </form>

        <div class="transparency-commitment">
            <h4>Our Verification Commitment</h4>
            <p>Every public submission receives response within 72 hours. Verified information is credited to contributors in our public database. Our expert verification network ensures accuracy while protecting legitimate whistleblowers and concerned citizens.</p>
        </div>
    </div>

    <!-- AI-Enhanced Analysis Panel -->
    <div class="subpanel" id="sub-ai" role="tabpanel" aria-labelledby="sub-ai-btn">
        <h3>AI-Enhanced Pattern Detection & Analysis</h3>
        <p>Our artificial intelligence systems serve as powerful analytical tools that can process vast amounts of legislative data to identify patterns and relationships that would be impossible for human analysts to detect manually. Think of these AI systems as highly sophisticated pattern recognition engines that work alongside our human experts to create a more complete picture of potential conflicts of interest.</p>

        <div class="ai-overview">
            <h4>How AI Enhances Transparency Analysis</h4>
            <p>The integration of machine learning algorithms into legislative transparency represents a significant advancement in our ability to detect subtle forms of influence and potential conflicts. These systems examine multiple data streams simultaneously, comparing legislative language against vast databases of industry documents while simultaneously analyzing financial patterns and behavioral anomalies. This multi-dimensional approach ensures that potential conflicts are identified even when they involve complex indirect relationships or sophisticated attempts at concealment.</p>
        </div>

        <div class="ai-insights">
            <h4>Real-Time Analysis Results</h4>
            <p>Our AI systems continuously monitor current legislative proposals and generate alerts when significant patterns are detected. Each analysis includes confidence scoring and supporting evidence that allows users to evaluate the strength of identified potential conflicts. The following examples demonstrate the types of patterns our systems regularly identify across different categories of legislative analysis.</p>

            <div class="insight-cards">
                <div class="insight-card">
                    <div class="insight-header">
                        <span class="insight-type">Legislative Language Analysis</span>
                        <span class="confidence-score">High Confidence: 87%</span>
                    </div>
                    <div class="insight-content">
                        <p>Healthcare Reform Bill Section 12 demonstrates <strong>72% textual similarity</strong> with pharmaceutical industry white paper published in 2023. The analysis reveals identical sentence structures, matching technical terminology, and parallel clause organization that suggests direct copying or heavy influence from industry-authored materials.</p>
                        <div class="evidence-summary">
                            <strong>Key Evidence:</strong> 247 matching phrases, 89 identical technical terms, 12 sequential paragraphs with >90% similarity
                        </div>
                    </div>
                    <div class="insight-actions">
                        <button class="btn-link">View Side-by-Side Comparison</button>
                        <button class="btn-link">Download Similarity Report</button>
                        <button class="btn-link">Access Source Documents</button>
                    </div>
                </div>

                <div class="insight-card">
                    <div class="insight-header">
                        <span class="insight-type">Financial Pattern Correlation</span>
                        <span class="confidence-score">Very High: 91%</span>
                    </div>
                    <div class="insight-content">
                        <p>Education Technology Bill Section 14 contains digital learning provisions that match vendor technical specifications with <strong>68% precision alignment</strong>. Concurrent analysis reveals the bill's primary sponsor received $45,000 in campaign contributions from companies that would directly benefit from these specific provisions, with timing that shows contributions arriving within 60 days of bill introduction.</p>
                        <div class="evidence-summary">
                            <strong>Financial Trail:</strong> 7 related entities, $45,000 total contributions, 60-day correlation window, 3 prior legislative collaborations
                        </div>
                    </div>
                    <div class="insight-actions">
                        <button class="btn-link">Interactive Timeline View</button>
                        <button class="btn-link">Detailed Contribution Analysis</button>
                        <button class="btn-link">Beneficiary Company Profiles</button>
                    </div>
                </div>

                <div class="insight-card">
                    <div class="insight-header">
                        <span class="insight-type">Behavioral Anomaly Detection</span>
                        <span class="confidence-score">Critical Alert: 94%</span>
                    </div>
                    <div class="insight-content">
                        <p>Statistical analysis identified a significant deviation from normal campaign contribution patterns, with donation volumes increasing by 340% in the 30-day period preceding a documented policy position reversal. This pattern repeats across three separate legislative initiatives by the same sponsor, suggesting systematic correlation between financial incentives and policy changes.</p>
                        <div class="evidence-summary">
                            <strong>Pattern Details:</strong> 3 legislative initiatives, 340% contribution spike, 30-day correlation window, 97% probability of non-random occurrence
                        </div>
                    </div>
                    <div class="insight-actions">
                        <button class="btn-link">Statistical Pattern Analysis</button>
                        <button class="btn-link">Historical Voting Comparison</button>
                        <button class="btn-link">Probabilistic Risk Assessment</button>
                    </div>
                </div>

                <div class="insight-card">
                    <div class="insight-header">
                        <span class="insight-type">Cross-Legislative Pattern Recognition</span>
                        <span class="confidence-score">Medium Confidence: 73%</span>
                    </div>
                    <div class="insight-content">
                        <p>Multi-bill analysis reveals that current Environmental Protection Amendment incorporates policy frameworks nearly identical to those found in legislation across 12 other states, suggesting coordinated industry influence campaign. Language similarity analysis indicates potential template distribution from common source organization.</p>
                        <div class="evidence-summary">
                            <strong>Geographic Scope:</strong> 12 states, 85% language similarity, 6-month introduction timeframe, common lobbying entities identified
                        </div>
                    </div>
                    <div class="insight-actions">
                        <button class="btn-link">Multi-State Comparison Map</button>
                        <button class="btn-link">Template Source Analysis</button>
                        <button class="btn-link">Lobbying Network Visualization</button>
                    </div>
                </div>
            </div>
        </div>

        <div class="ai-methodology">
            <h4>Technical Analysis Methods</h4>
            <p>Understanding how our AI systems work is crucial for evaluating the reliability and significance of their findings. Each analytical method serves a specific purpose in building a comprehensive picture of potential legislative conflicts, and the combination of these approaches provides robust detection capabilities that individual methods could not achieve alone.</p>

            <div class="methodology-grid">
                <div class="method-item">
                    <h5>Advanced Natural Language Processing</h5>
                    <p>Our NLP systems employ transformer-based language models trained specifically on legislative and policy documents to identify semantic similarities that extend beyond simple word matching. The system compares bill text against databases containing over 2.3 million industry documents, lobbying materials, think tank publications, and previous legislative proposals. This analysis can detect when legislative language has been adapted from external sources even when surface-level paraphrasing attempts to obscure the relationship.</p>
                    <div class="method-stats">
                        <span class="stat-item">Documents Analyzed: 2.3M+</span>
                        <span class="stat-item">Languages Supported: 12</span>
                        <span class="stat-item">Accuracy Rate: 94.7%</span>
                    </div>
                </div>

                <div class="method-item">
                    <h5>Temporal Pattern Recognition</h5>
                    <p>Time-series analysis algorithms examine the temporal relationships between financial transactions, policy announcements, legislative introductions, and voting behaviors. The system establishes baseline patterns for each legislator and identifies statistically significant deviations that may indicate external influence. Machine learning models trained on historical data can predict the probability that observed timing correlations occurred by chance versus deliberate coordination.</p>
                    <div class="method-stats">
                        <span class="stat-item">Time Windows: 1 day to 5 years</span>
                        <span class="stat-item">Variables Tracked: 847</span>
                        <span class="stat-item">Prediction Accuracy: 89.3%</span>
                    </div>
                </div>

                <div class="method-item">
                    <h5>Multi-Layer Network Analysis</h5>
                    <p>Graph neural networks map complex webs of relationships connecting legislators, corporations, lobbying firms, campaign contributors, and policy beneficiaries. The system identifies indirect influence pathways that may span multiple degrees of separation, revealing hidden connections that traditional analysis might miss. Network centrality algorithms highlight entities that serve as crucial bridges in influence networks, even when their direct involvement appears minimal.</p>
                    <div class="method-stats">
                        <span class="stat-item">Network Nodes: 1.8M+</span>
                        <span class="stat-item">Relationship Types: 23</span>
                        <span class="stat-item">Connection Depth: 6 degrees</span>
                    </div>
                </div>

                <div class="method-item">
                    <h5>Behavioral Anomaly Detection</h5>
                    <p>Unsupervised learning algorithms establish normal behavioral baselines for individual legislators based on their historical voting patterns, campaign finance activities, and policy positions. The system then identifies significant deviations from these established patterns, particularly when such changes correlate with external events like major contributions or lobbying contacts. Ensemble methods combine multiple detection approaches to minimize false positives while maintaining high sensitivity to genuine anomalies.</p>
                    <div class="method-stats">
                        <span class="stat-item">Behavioral Metrics: 156</span>
                        <span class="stat-item">Detection Algorithms: 8</span>
                        <span class="stat-item">False Positive Rate: 3.2%</span>
                    </div>
                </div>
            </div>
        </div>

        <div class="ai-validation">
            <h4>Human Expert Validation Process</h4>
            <p>AI-generated insights undergo rigorous validation by subject matter experts before inclusion in public reports. This hybrid approach combines the pattern detection capabilities of machine learning with the contextual understanding and domain expertise that only human analysts can provide. Expert reviewers evaluate each AI finding for accuracy, relevance, and potential alternative explanations, ensuring that technological capabilities enhance rather than replace human judgment in matters of such significant public importance.</p>

            <div class="validation-pipeline">
                <div class="validation-step">
                    <div class="step-indicator">1</div>
                    <div class="step-content">
                        <h5>Automated Initial Screening</h5>
                        <p>AI systems flag potential conflicts above predetermined confidence thresholds and generate supporting evidence packages for human review.</p>
                    </div>
                </div>
                <div class="validation-step">
                    <div class="step-indicator">2</div>
                    <div class="step-content">
                        <h5>Expert Domain Analysis</h5>
                        <p>Subject matter specialists evaluate AI findings within broader policy context, considering factors like legislative precedent and industry norms.</p>
                    </div>
                </div>
                <div class="validation-step">
                    <div class="step-indicator">3</div>
                    <div class="step-content">
                        <h5>Independent Verification</h5>
                        <p>Secondary analysts independently verify AI-identified patterns using alternative methodologies and data sources to confirm findings.</p>
                    </div>
                </div>
                <div class="validation-step">
                    <div class="step-indicator">4</div>
                    <div class="step-content">
                        <h5>Public Disclosure Decision</h5>
                        <p>Editorial board reviews validated findings and determines appropriate disclosure level based on evidence strength and public interest significance.</p>
                    </div>
                </div>
            </div>
        </div>

        <div class="export-controls">
            <h4>Research Data Access & Transparency Tools</h4>
            <p>Complete transparency requires that our analytical methods and underlying data remain accessible to independent researchers, academic institutions, and civil society organizations. We provide multiple pathways for accessing both our processed analysis results and the raw data that supports our findings, enabling independent verification and fostering collaborative research into legislative transparency challenges.</p>

            <div class="access-tiers">
                <div class="access-tier">
                    <h5>Public Access Tier</h5>
                    <p>Summary reports, aggregate statistics, and non-sensitive analytical results available for immediate download. Includes educational materials explaining our methodology and interpretation guidelines for non-expert users.</p>
                </div>
                <div class="access-tier">
                    <h5>Research Partnership Tier</h5>
                    <p>Academic institutions and qualified research organizations can access detailed datasets, analysis code, and collaborative research tools through our verified partnership program.</p>
                </div>
                <div class="access-tier">
                    <h5>Developer API Access</h5>
                    <p>Technical developers can integrate our analysis capabilities into independent applications and research tools through documented API endpoints with appropriate rate limiting and usage guidelines.</p>
                </div>
            </div>

            <div class="export-options">
                <button class="btn-secondary">Download Analysis Summary (PDF)</button>
                <button class="btn-secondary">Export Pattern Data (CSV/JSON)</button>
                <button class="btn-secondary">Access Research API Documentation</button>
                <button class="btn-secondary">Request Partnership Access</button>
            </div>
        </div>
    </div>
    </div>
</div>


        <div class="verification-prompt">
            <p>Was this analysis helpful in understanding potential conflicts of interest?</p>
            <div class="verification-buttons">
                <button class="verification-btn btn-agree">Yes, Very Helpful</button>
                <button class="verification-btn btn-neutral">Somewhat Helpful</button>
                <button class="verification-btn btn-disagree">Not Helpful</button>
            </div>
        </div>



        </div>
    </div>
</div>

    <footer>
        <div class="footer-content">
            <div class="footer-logo">Chanuka</div>
            <div class="footer-links">
                <a href="#" class="footer-link">About</a>
                <a href="#" class="footer-link">Privacy</a>
                <a href="#" class="footer-link">Terms</a>
                <a href="#" class="footer-link">Contact</a>
            </div>
            <p class="footer-disclaimer">¬© 2025 Chanuka - Transparency in Governance Platform. All information is provided for educational purposes only.</p>
        </div>
    </footer>
   <script src="js/tabs.js"></script>
   <script src="js/utils.js"></script>
   <script src="js/bill-sponsorship.js"></script>
</body>
</html>
